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On our website, readers can submit class notes or a 
change of address, check the alumni events calendar, 
arrange for a lifelong Yale e-mail alias through the 
virtual Yale Station, and search our electronic archive.
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C O N T E N T S
o n the cov er  Science and archi-
tecture are moving away from the 
era in which a laboratory was built 
to order for a single scientist. New 
buildings and renovations to older 
ones aim to provide more support 
space for scientists, as well as more 
flexibility. Modern lab buildings 
include a little wiggle room, includ-
ing common areas that encourage 
mingling among scientists. 
Illustration by Shane McGowan
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Additional content for articles  
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is available online at iTunesU,  
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Congratulations for  
embracing pa program
I was very pleased to see the 
Yale Physician Associate Program 
featured in the Autumn 2009 
issue of Yale Medicine [“Yale’s 
Physician Associate Program 
Nears 40”], and to read the his-
tory of how the program came 
to be and how it has success-
fully evolved since 1970. Several 
points deserve emphasis. While 
the Duke program preceded the 
founding of ours by five years, it 
focused heavily on returning U.S. 
military corpsmen, which was 
not the emphasis of the Yale pro-
gram, even from the beginning. 
The Yale program drew its appli-
cants from a broad spectrum of 
individuals who had health care 
experience and were committed 
to working in some aspect of pri-
mary care. Although the program 
was born out of the trauma pro-
gram under the Department of 
Surgery chaired by Jack W. Cole, 
m.d., all students received gener-
alist training across the medical 
landscape and were prepared to 
enter any field of medicine. From 
the beginning, the faculty and 
leadership of the entire Medical 
School were very supportive.
The program leadership, 
including Blair L. Sadler, j.d., Ann 
A. Bliss, r.n., and Paul Moson, 
pa-c, was committed to a pro-
gram that was open equally 
to women and men. Although 
the first classes had more men 
than women, the applicant pool 
quickly evolved to the point that 
there were more women than 
men. Recent classes have more 
than 70 percent women, which 
corresponds to the national 
average. The white paper on the 
future of the physicians’ assis-
tants, prepared for five national 
foundations by Sadler, Sadler, and 
Bliss in 1971, drew the blueprint 
for the evolution of the field 
and served as the basis of the 
first policy book on pas that is 
still used in programs today, The 
Physician’s Assistant—Today and 
Tomorrow (Yale University Press, 
1972). The Yale pa Program con-
tinues to provide national leader-
ship through its faculty directed 
by Mary Warner, pa-c, and by its 
how to reach us
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accomplished graduates, who 
now number more than 900.
Congratulations to Yale 
School of Medicine for embrac-
ing a bold experiment in medical 
education that enhanced its 
development and provided lead-
ership for the field nationally.
Alfred M. Sadler Jr., m.d.
Founding Director, Yale pa Program
Strong forces aligned 
against medicine
“Doctors for America,” which 
appeared in the Winter 2010 issue 
of Yale Medicine, emphasized 
the need for physicians to be 
engaged in health reform.
Never have the forces aligned 
against medicine been so numer-
ous and so strong. The destiny of 
the profession has been jerked 
out of physicians’ hands by insur-
ance and drug companies. Their 
profit-based goals undermine 
medicine’s humanism. Thus 
Doctors for America’s efforts to 
recruit physicians to protect the 
heart and soul of medicine are as 
necessary as they are admirable.
Two issues resonated strongly 
with me: increasing the reim-
bursements for primary care phy-
sicians and eliminating the defects 
of the malpractice system.
As is widely known, most 
students are turned off by pri-
mary care. But merely paying 
these physicians more for their 
services is not the whole answer. 
Their training should be more in 
touch with what the real world 
requires of them. In my pre-med 
years I knew several students 
who would have made excellent 
general practitioners but who, 
because of average grades in 
organic chemistry or biochem-
istry, lost out on their dreams of 
becoming physicians.
Making the basic science 
courses less intensive for those 
interested in primary care would 
attract more into the specialty. 
This sounds heretical, but most 
primary care doctors have no 
need for the organic chemistry 
and physics and biochemistry that 
they endured as rites of passage. 
The biggest problem with 
the malpractice system is that 
it allows unpreventable bad 
outcomes to be misconstrued as 
malpractice. Because malpractice 
suits can seriously harm physi-
cians’ reputations and livelihoods, 
many doctors order tests and 
consultations that are not neces-
sary specifically to ward them off. 
Not only does this raise the cost 
of health care immensely but it 
exposes patients to risky proce-
dures and medications.
One thing is certain: Without 
strong physician engagement, the 
destiny of the medical profession 
will remain in the hands of those 
whose methods and goals under-
mine the humanitarian impulses 
that attracted most doctors to 
medicine in the first place.
Edward J. Volpintesta, m.d.
Bethel, Conn.
No guarantee of  
happiness in life
The article in the Winter 2010 
issue [“Doctors for America”] 
floored me with its naïve egalitar-
ian comments, especially from 
young physicians. The commen-
tators bemoaned inequality in 
health care access and that health 
care is not a right, and argued 
for the need for comprehensive 
services—including that sticky 
marshmallow, mental health. 
Theoretically there may be 
equality of opportunity, even fair-
ness under law, but emphatically 
people are not clones. We are not 
all tall, blond, and blue-eyed; I cer-
tainly am not (just informed, realis-
tic, and elegant, which is enough).
We are not guaranteed certi-
fied Grade A parents. So far the 
government does not send a nice 
cake and a sunny day on your birth-
day. There never will be enough 
Château Palmer for everyone.
People are much different in 
abilities and fortunes. There may 
be a right to pursue happiness, but 
there is no guarantee thereof. The 
good die young and I am retired.
Eugene Patrick Cassidy, m.d. ’66
Marshalltown, Iowa
3starting point
In February about a dozen alumni, as well as past and current faculty members, came together at 
New Haven’s Lawn Club for the inaugural meeting of Yale Medicine’s advisory board. The group 
spanned the decades and created some interesting juxtapositions as former students engaged 
their former teachers in a new forum. (One alumna later commented that it was the first time 
she’d seen the face of a surgeon who’d been her teacher—as a student she’d seen only his eyes 
peering out from above his mask in the operating room.)
The group owes its existence to our readers’ survey, which we completed last year. 
The feedback from the survey was resoundingly positive; we thought an advisory board would 
allow us to extend and maintain our links to our readership. We asked about 15 alumni and fac-
ulty members to gather twice a year to tell us what they like about Yale Medicine, what they think 
could be better, and what they’d like to see in its pages. We also asked the members—several of 
whom are authors and whose numbers include a nationally recognized writer/physician, a lead-
ing cardiothoracic surgeon, and a former deputy dean—to serve as a sounding board and offer 
their advice in their respective areas of expertise.
At this first meeting the conversation continued more than half an hour past our allotted 
time; it was another half hour before everyone left. Members of the new advisory board 
bombarded us with topics and ideas for future articles in Yale Medicine. We hope to see many of 
these ideas in the pages of the magazine or in our Online Extra edition. Thanks to all the board 
members who offered their time, expertise, and wisdom.
John Curtis
Managing Editor
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Cushing collection once 
again open for research
Library makes a new home for  
the tumor registry while an autopsy  
vindicates the neurosurgeon.
Over the years, in what became a rite of 
passage, Yale students would break in—
by unscrewing a door panel and squeez-
ing inside—to a room in the basement 
of Harkness Dormitory. It is a daunting 
trek, dimly lit, beneath oversized heat-
ing and ventilation ducts and through 
spaces that haven’t seen a broom or 
mop in years. The students came to see 
the brains. Hundreds were lined up 
on dusty metal shelves, submerged in 
cloudy formaldehyde, their gray matter  
crumbling at the edges. Since the 
mid-1990s and continuing to this day, 
students paid their respects by signing 
a poster in the room, thereby becoming 
members of the “Brain Society.”
“The pledge on the poster was ‘Take 
Only Memories,’ ” said Terry Dagradi,  
a photographer at the medical school 
who has been working on the preserva-
tion and cataloging of the collection’s 
archive of patient photographs.
The brains belonged to patients of 
Harvey Cushing, m.d., the pioneering 
neurosurgeon, who preserved them as 
part of his tumor registry and left them 
to Yale upon his death in 1939. In stor-
age since the 1950s, they are about to 
come to light again. During the 1990s 
Christopher Wahl, m.d. ’96, wrote 
his thesis on the collection, bringing 
new attention to the Cushing brains. 
Now, under the direction of Dennis D.  
Spencer, m.d., hs ’76, chair and 
Harvey and Kate Cushing Professor of 
Neurosurgery, the collection is being 
restored and moved to a “brain library” 
within the medical library. The Cushing 
Center, designed by architect Turner 
Brooks, will display all 550 brains in 
jars. Some will be shown alongside 
Cushing’s meticulous medical records 
and striking photographs of patients.  
“I don’t know of another library that 
has a collection of autopsied preserved 
brains as their primary holdings,”  
said Spencer.
When he began the project in 2005, 
much of the brains’ formaldehyde had 
partly evaporated long ago, and what 
chronicle news from cedar street
t o p  Pioneering neurosurgeon Harvey Cush-
ing’s tumor registry included detailed records 
of each patient, photographs of the patients, 
brains, and tumor samples. The collection, which 
had been stored in a basement room under the 
Harkness dormitory, is moving to a new home—
the Cushing Center in the Cushing/Whitney 
Medical/Historical Library.
le f t  Dennis Spencer, chair of neurosurgery, 
holds a specimen in the basement where the 
Cushing tumor registry has been stored. Spencer 











Dennis Spencer: Doctors Develop Surgical Cure 
for Epilepsy by Watching the Brain at Work
5
ventricles of the brain filled with blood. 
Devastated, he preserved both brain and 
tumor and wrote up the case in his  
1938 textbook, Meningiomas, which he 
co-authored with neuropathologist 
Louise Eisenhardt, m.d. With custom-
ary precision and candor, he blamed 
himself for failures of surgical judg-
ment. He retired five years later.
“It’s amazing how these two men’s 
careers were so much in parallel,” said 
Spencer. “They crossed at the beginning 
of their careers and again at the end.”
Spencer and St. Pierre recently re-
autopsied Wood’s brain to learn more 
about his death; Spencer had suspected 
that a bleeding vessel from the tumor 
was the culprit. But he could find none, 
and he now thinks the primitive blood 
transfusion practices of the day may 
have disturbed Wood’s clotting mecha-
nisms and led to the deadly bleed. 
It was postmortem examinations like 
these that made the Cushing brains such 
an important resource. Before imaging 
technology was available, surgeons and 
pathologists studied gross specimens to 
see damage wrought by strokes, tumors, 
or injuries. But few brains are saved 
today, since autopsies are falling out of 
favor—CT and mri are the preferred 
teaching tools. Yet even though they’re 
not used for didactic purposes, said 
Spencer, the brains are “beautiful and 
historic.” And as the students knew, they 
make an impressive sight. Alongside 
Cushing’s detailed writings and photo- 
graphs, they embody memories of neuro- 
surgery’s pioneering era.
—Jenny Blair
et cetera • • •remained was dirty. The jars had leaky seals and were coated in filth. Nicole  
St. Pierre, who holds a degree in foren-
sic science and will soon begin training 
as a physician associate, is cleaning 
them and replacing the preservative. 
Dagradi and others will coordinate  
the displays. The Cushing Center will 
open on June 5, with Kate Cushing, 
Harvey Cushing’s granddaughter, tak-
ing part in the ribbon cutting.
Perhaps the most famous brain in 
the collection belonged to a well-known 
figure of the early 1900s: Major General 
Leonard Wood, m.d. A physician and 
friend of Theodore Roosevelt, he led 
the Rough Riders’ charge up San Juan 
Hill, and was governor of Cuba and the 
Philippines. In 1904, in his 40s, Wood 
suffered seizures in his left leg. For a 
time, he treated them by sniffing chloro-
form. But after a few years the seizures 
and a growing lump on his skull could 
no longer be ignored. Cushing agreed 
to operate, though no one at the time 
had much experience in removing brain 
tumors. In a groundbreaking 1910 opera-
tion at Johns Hopkins, Cushing removed 
a large benign growth; it proved to be a 
meningioma, a tumor of the lining of 
the brain. Wood was cured of his sei-
zures and resumed his active life, which 
included service as Army chief of staff 
and a candidacy for the Republican presi-
dential nomination in 1920.
The success of the operation so 
impressed a group of Harvard physi-
cians that they invited Cushing to 
relocate to the brand-new Peter Bent 
Brigham Hospital in Boston. He 
agreed and went on to become the 
father of neurosurgery.
But Wood’s tumor recurred, forc-
ing him to return from the Philippines 
in 1927. Cushing, by now far more 
experienced, operated again, and found 
a second meningioma almost twice 
the size of the first. After a difficult 
operation and much blood loss it was 
removed and the patient appeared to be 
recovering. A few hours later, though, 
Wood became unresponsive and died. 
Cushing autopsied him and found the 
WE B S ITE TR ACK S A R R A F U N D I N G
Since February 2009 Yale faculty have received 
more than 280 research awards with a value 
of $121 million through the American Recovery 
and Reinvestment Act (arra). The act’s goal 
is to reinvigorate the economy and stimulate 
long-term growth through increased invest-
ments in infrastructure, education, the environ-
ment, and scientific research.
The university in January debuted a web-
site designed to provide information about 
grants received through arra. The website, 
opa.yale.edu/sp/arra1/, includes vignettes 
of faculty research, background informa-
tion on the competitive process used to select 
applications, and such key statistics as the 
number of jobs created or retained through 
arra-funded projects. The site also links to a 
site developed by the Association of American 
Universities, the Association of Public and 
Land Grant Universities, and the Science 
Coalition. That site demonstrates the impact 
of arra funding at research universities 
across the country. 
—John Curtis
YA LE D O CS O N H A ITI  M I SS I O N
Six health professionals from the School 
of Medicine and Yale-New Haven Hospital 
treated about 400 victims of the Jan. 12 
earthquake at a hospital in the town of 
Hinche in February.
“We were careful to make sure that we 
took the right people with the right stuff to 
the right place,” said Gregory Luke Larkin, m.d., 
professor of emergency medicine. Although 
the earthquake struck Port-au-Prince, many 
patients are being sent to other sites for 
medical treatment. 
The team brought $12,000 worth of equip-
ment and supplies, as well as their own food 
and water. “We didn’t need to drain any of the 
local resources,” said Larkin.
The group treated fractures and crush inju-
ries, many of which were worsened by delays 
in obtaining medical care. Wounds that would 
have been minor if treated early became 
infected, often requiring amputation. 
Medical teams continue to arrive in Haiti 
to relieve one another. “We handed off the 
baton,” said Larkin, “but the road to recovery 















chronicle news from cedar street
A video game to help teens 
make the right choices about 
preventing hiv
For many teenagers, the high point 
of an interactive video game is being 
as bad as they can be—crashing the 
most vehicles or squashing the most 
opponents. Between them, Lynn E. 
(Sullivan) Fiellin, m.d. ’96, hs ’00, and 
David A. Fiellin, m.d., hs ’95, have five 
children ranging in age from 11 to 20, 
and as Lynn Fiellin watched them play 
their video games she realized that she 
could tweak that concept. She envi-
sioned an interactive game in which 
kids score points not by pulverizing 
opponents but by making choices that 
could help them reduce risk behaviors 
and avoid hiv infection.
This year the Eunice Kennedy Shriver 
National Institute of Child Health and 
Human Development gave the School 
of Medicine a five-year research grant  
to develop and test such a game. Fiellin, 
assistant professor of medicine, has 
gathered a team of like-minded experts, 
including her husband, an associate  
professor of medicine and an addiction  
researcher, and other Yale faculty. Fiellin  
is working with such experts as Alex-
ander Seropian, executive producer of 
the popular Halo science fiction video 
game, on game design and development. 
Ben Sawyer, co-founder of the Games for 
Health Project, funded by the Pioneer 
Portfolio of the Robert Wood Johnson 
Foundation, is assisting as a consultant 
working with other game designers.
“Harnessing technology for health 
behavior games is a vastly growing area,” 
said Fiellin, an attending physician in 
Yale’s Primary Care Center and Nathan 
Smith hiv Clinic. 
The game is still in its earliest stages  
of development, but Fiellin envisions 
an interactive world in which the player, 
using an avatar (virtual character), 
“travels” through life, making decisions 
that bring different risks and benefits. 
The players will be able to see how their 
choices affect their lives and can move 
back in time to see how different actions 
might lead to different outcomes. By nego-
tiating challenges in a highly repetitive 
and meaningful way, the player should 
learn skills that equip him or her to avoid 
real-life situations that increase their risk 
of hiv. “Through the video game play we 
can evaluate in real-time how our players 
are acquiring skills to help them make 
better choices,” Fiellin said.
She plans to conduct a randomized 
clinical trial with 330 ethnically diverse 
children between 11 and 14 years old at 
an after-school program in a New Haven 
community center in order to study the 
game’s impact on delaying the age of  
initial sexual activity. She expects even-
tually to distribute the game to schools 
throughout the country, although teen-
agers can also play it at home, on cell 
phones, or on personal digital assistants. 
The game has international implications, 
as access to the Internet is on the rise in 
developing countries that have growing 
hiv epidemics but only limited access to 
targeted risk-reduction strategies.
In 2006, more hiv infections oc-
curred in individuals between the ages of 
13 and 29 than in any other age group in 
the United States, according to the most 
recent figures available from the Centers 
for Disease Control and Prevention. “If 
we start teaching kids about risky behav-
iors early,” Fiellin said, “maybe we can 
prevent some cases of hiv.” 
—Kathy Katella
7
“Amazing” rnas found 
to play a more complex role  
than thought
Any biology textbook will depict pro-
teins as the workhorses that carry out 
the lion’s share of biochemical reactions 
in cells. Aside from a few exceptions, 
however, rnas have largely been pigeon-
holed as passive middlemen between 
dna and proteins. 
New findings from the laboratory of 
Ronald Breaker, ph.d., Henry Ford II 
Professor of Molecular, Cellular, and 
Developmental Biology, and Howard 
Hughes Medical Institute Investigator, 
suggest that rnas play a more complex 
role than previously thought, and that, 
in certain tasks in certain organisms, 
they take on a more dominant role 
than proteins. Breaker and colleagues 
have discovered a slew of large rnas 
that do not code for proteins but in-
stead form complex three-dimensional 
structures in simple organisms like 
bacteria—structures that may carry out 
complex biochemical functions. “Every 
time we feel as though we’re giving rna 
just about the right amount of credit, we 
find more amazing rnas,” said Breaker. 
“I think this is just a continuation  
of the data that forces us to move our 
standards ever higher for what we think 
rna should be able to do.”
First author Zasha Weinberg, ph.d., 
a postdoc in Breaker’s lab, and colleagues 
reported in the December 3 issue of 
Nature on several new large noncod-
ing rnas in bacteria, two of which the 
research team christened golld and 
hearo. Preliminary work suggests that 
golld helps viruses that infect bacteria 
to burst out of infected cells so that they 
can seek new targets, whereas hearo 
might be a mobile genetic element, 
which are present in all organisms and  
a cause of spontaneous genetic change.
Breaker’s group culled these and 
other noncoding rnas out of stretches 
of “junk dna” that do not code for 
proteins. The researchers matched junk 
dna sequences between related bacteria 
to identify stretches that were highly con-
served—a red flag that signals evolution-
ary preservation and perhaps importance. 
They then looked at these conserved dna 
sequences to pick out regions that, when 
transcribed into rna, could form com-
plex rna structures—hairpins, loops, 
and knots—enabling them to sift out 
the probable noncoding rnas.
Breaker hasn’t determined whether 
these noncoding rnas represent living 
relics of an ancient rna-centered world 
that might have existed before proteins 
evolved and drove many catalytic rnas 
to extinction, or whether they represent 
more modern developments. 
Whatever their origin, given the 
number of noncoding rnas that Breaker 
suspects may be active in select organ-
isms, he feels it is important to come 
to grips with how modern cells really 
function. “It’s not that the science that 
we know about modern cells is wrong, 
but as we find more and more noncod-
ing rnas, we recognize how incomplete 
our understanding is,” Breaker said.
—Kara A. Nyberg
et cetera • • •
M E D I C A L E X PE R T S FO R M E D I A
Yale Medical Group (ymg) in December launched 
a website that offers access to 90 specialists in 
clinical care and scientific research to journal-
ists on deadline. The scientists on this website 
represent some of the nearly 800 members  
of ymg who treat patients, teach, and conduct 
research at Yale.
The website, opa.yale.edu/experts, can 
also be accessed through the Office of Public 
Affairs, opa.yale.edu, by clicking on the link 
“For The Media: Find a Medical Expert.”
The site contains more than 50 categories 
of experts, with photos, profiles, and video 
clips of the experts and a link to their contact 
information. Instructions are also available 
for setting up remote television or radio inter-
views with the Yale experts. (Yale University 
maintains a professional radio and television 
broadcast studio in New Haven with full satel-
lite transmission capability.)
—John Curtis
N A N O S E N S O R S TE ST FO R C A N CE R
Yale researchers have for the first time used 
nanosensors to measure two cancer biomark-
ers in whole blood, opening up the possibility 
of simpler testing for cancer and other diseases.
“Nanosensors have been around for the 
past decade, but they only worked in con-
trolled laboratory settings,” said Mark A. Reed, 
ph.d., the Harold Hodgkinson Professor of 
Engineering and Applied Science and Electrical 
Engineering. “This is the first time we’ve been 
able to use them with whole blood, which is  
a complicated solution containing proteins, 
ions, and other things that affect detection.”
Reed and Tarek Fahmy, ph.d., associ-
ate professor of biomedical and chemical 
engineering, reported on December 13 in 
the advance online publication of Nature 
Nanotechnology that they had developed 
a device that can detect concentrations 
equivalent to a grain of salt in a swimming 
pool. The device can detect biomarker con-
centrations in minutes instead of days and 
could test for a wide range of biomarkers for 




Ronald Breaker:  
Riboswitches: Nature’s Ancient Turn-On
10 Nucleotides
A typical rna molecule (above) involved in 
transfer of genetic information is dwarfed by the 
rna molecule golld (below), the third-largest 
and most complex rna discovered to date. golld 

























Blows to the Head: How  
Boxing Changed My Mind
by Binnie Klein, m.s.w., lecturer in 
psychiatry (State University of New 
York Press) The author offers a 
series of memories and insights 
from an unlikely contender. Klein’s 
unexpected midlife fascination 
with boxing takes her beyond the 
ring, leading her back to her roots 
and to a surprising chapter of  
the Jewish immigrant experience. 
Klein shows us that if we turn over 
the “weird stones” on our path—
the ones we usually ignore—we 
may find ourselves on a remark-
able and revitalizing journey. 
Human-Animal Medicine:  
Clinical Approaches to Zoonoses, 
Toxicants and Other Shared 
Health Risks
by Peter M. Rabinowitz, m.d., 
m.p.h., associate professor of medi-
cine; and Lisa A. Conti, d.v.m., 
m.p.h. (Saunders) This reference 
work explores the convergence  
of human, animal, and environ-
mental health concerns. It calls 
for greater communication and 
cooperation among human health 
care providers, public health pro- 
fessionals, and veterinarians to  
address vital issues of emerging  
diseases and environmental 
change. This book provides practi-
cal guidelines for collaborations 
on a wide range of clinical human-
animal health issues, including 
the H1N1 virus, zoonotic diseases, 
the human-animal bond, animal 
allergy, bites and stings, and 
animals as sentinels of environ-
mental health hazards.
Acute Pain Management
by Raymond S. Sinatra, m.d., 
ph.d., professor of anesthesiology; 
Oscar A. DeLeon-Cassasola, m.d.; 
Eugene Viscusi, m.d.; and Brian 
Ginsberg, m.d. (Cambridge Uni-
versity Press) This textbook pro-
vides a comprehensive overview of 
acute pain management, including 
the anatomy of pain pathways; 
the pathophysiology of severe 
pain; pain assessment; therapeutic 
guidelines and analgesic options; 
organization of pain services; and 
the roles of anesthesiologists, 
surgeons, pharmacists, and nurses 
in providing optimal care.
Pathology of the Breast
by Fattaneh A. Tavassoli, m.d., 
professor of pathology (McGraw-
Hill Companies) This book 
provides information on all 
benign and malignant lesions of 
the breast. It focuses on facts and 
details that pathologists need to 
make precise critical diagnoses: 
morphological features, differen-
tial diagnoses, and diagnostic aids 
for both common and rare lesions 
in men as well as in women.  
The book includes illustrations, 
photographs, photomicrographs, 
and extensive literature reviews.
Speech Sound Disorders  
in Children: In Honor  
of Lawrence D. Shriberg
edited by Rhea Paul, ph.d., 
ccc-slp, lecturer in the Child 
Study Center; and Peter Flipsen Jr., 
ph.d. (Plural Publishing) This text 
provides insights from a variety 
of perspectives and disciplines 
into the development of children’s 
speech sounds. The authors dis-
cuss the difficulties in the analysis 
of and treatment implications for 
both specific speech disorders  
and the speech of children with 
other primary disabilities. 
books & ideas
Getting the science on paper
A new guide helps scientists avoid basic writing mistakes 
and express their ideas clearly.
Angelika H. Hofmann, ph.d., conducted a modest study before 
beginning her book on scientific writing. To gauge the state of 
the art, Hofmann examined 100 prepublication drafts of scien-
tific papers. She found pervasive problems: unnecessary repeti-
tion, over-long sentences, missing information, and faulty verb 
tenses. Three out of four authors had misplaced or omitted such 
an essential element of the paper as 
the purpose of the experiment.
Hofmann’s new book, Scientific 
Writing and Communication, pro-
vides a broad-spectrum remedy 
for such ills. In 700 pages, she 
offers step-by-step instructions for 
producing research papers, review 
articles, grant proposals, posters, 
talks, and job applications.
Hofmann, a writer and grant  
editor at Yale’s Office of Develop-
ment and an adjunct instructor 
who teaches Scientific Writing I, 
begins with such fundamental 
principles of composition as keep-
ing tenses straight and sentences 
short. She addresses such topics 
as using references, avoiding 
plagiarism, overcoming writer’s 
block, and choosing between figures and tables to report data. 
Summary boxes and revision checklists consolidate informa-
tion. The book includes samples of both good and bad writing, 
alongside suggested revisions for the clunkers.
Hofmann estimates that about half of scientists writing in 
English are not native speakers; throughout, she includes notes 
addressing such writers. Each chapter ends with exercises, 
and answers appear in the back of the book.
As Hofmann points out, the scientific enterprise requires 
not only running sound experiments but also disseminating 
results. Skillful communication, she writes, “is the engine that 
propels virtually all scientific progress.”
—Cathy Shufro
Scientific Writing  
and Communication: 
Papers, Proposals,  
and Presentations
By Angelika H. Hofmann, 
ph.d., writer and grant 
editor for corporate and 
foundation relations, Yale 




Scientific Writing and Communication: Papers, Proposals, and Presentations covers all the areas of scientific 
communication that a scientist needs to know and to master to successfully promote his or her research and 
career. This unique “all-in-one” handbook begins with a discussion of the basics of scientific writing style and 
composition and then applies these principles to writing research papers, review articles, grant proposals, 
research statements, and résumés as well as to preparing academic presentations and posters.
F E A T U R E S
A practical presentation•	  carefully introduces such basic writing mechanics as word choice and word location, 
sentence structure, and paragraph organization before moving into manuscript planning and organizational 
strategies. Extensive hands-on guidance for composing scientific documents and presentations then follows. 
Relevant and multi-disciplinary examples•	  taken from real research papers and grant proposals by 
writers ranging from students to Nobel Laureates illustrate clear technical writing as well as common mistakes 
that one should avoid. Examples are drawn from a broad range of scientific disciplines including medicine, 
molecular biology, biochemistry, ecology, geology, chemistry, engineering, and physics.
Extensive end-of-chapter exercise sets•	  provide the opportunity to review style and composition prin-
ciples and encourage readers to apply them to their own writing. 
Writing guidelines and revision checklists•	  warn scientists against common pitfalls and equip them 
with the most successful techniques to revise a scientific paper, review article, or grant proposal. 
Annotated text passages•	  bring the writing principles and guidelines to life by applying them to real-world, 
relevant and multidiscipline examples.  
Clear, easy-to-follow writing style•	  is understandable to both native and non-native English speakers; 
special ESL features address problems faced by non-native English speakers.
Eight chapters on grant writing•	  demonstrate how to write successful grant applications and how to 
avoid the most common application mistakes.
Covering all the facets of communication that scientists need to master, Scientific Writing and Communication: 
Papers, Proposals, and Presentations is ideal for a wide range of readers—from upper-level undergraduates 
and graduate students to postdoctoral fellows, faculty, and professional researchers—in the life sciences, 
medicine, psychology, chemistry, and engineering. 
A b o U T  T h E  A U T h o R
Angelika H. Hofmann is Instructor for Scientific Writing at Yale University.
C o v e r 	 d e s i g n : 	 T.	reitzle/oxygen	design	group
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Letters to a Best Friend
by Richard Selzer, m.d., hs ’61; 
Peter Josyph, editor (suny Press) 
This book is the record of two 
decades of written conversation 
between two friends: Selzer, the 
essayist, short story writer, and 
former surgeon; and Peter Josyph, 
a New York painter, actor, and 
filmmaker who began the corre-
spondence in 1988. The book is an 
edited selection of the thousands 
of letters that Selzer wrote about 
his life, his work, and his friend-
ship with Josyph.
The Treatment of Eating  
Disorders: A Clinical Handbook
by Carlos M. Grilo, ph.d., profes-
sor of psychiatry and psychology; 
and James E. Mitchell, m.d. 
(The Guilford Press) This clinical 
handbook brings together leading 
international experts on eating 
disorders to describe the most 
effective treatments and their 
implementation. Coverage en-
compasses psychosocial, family-
based, medical, and nutritional 
therapies for anorexia nervosa, 
bulimia nervosa, binge eating 
disorder, and other disorders and 
disturbances. The volume also 
provides an overview of assess-
ment, treatment planning, and 
medical management issues. 
Special topics include psychiatric 
comorbidities, involuntary treat-
ment, support for caregivers,  
eating disorders in children, and 
new directions in treatment 
research and evaluation.
Health and Social Justice
by Jennifer Prah Ruger, ph.d., 
associate professor of public  
health (Oxford University Press) 
Societies make decisions and take 
actions that profoundly affect 
the distribution of health care. 
Why and how should collective 
choices be made and policies 
implemented to address health 
inequalities under conditions of 
resource scarcity? How should so-
cieties conceptualize and measure 
health disparities, and determine 
whether they’ve been adequately 
addressed? Who is responsible for 
various aspects of this important 
social problem? In this book Ruger 
elucidates principles to guide 
these decisions, the evidence that 
should inform them, and the  
policies necessary to build equi-
table and efficient health sys- 
tems worldwide. 
Netter’s Gastroenterology, 2nd ed.
by Martin H. Floch, m.d., clinical 
professor of medicine; Neil R. 
Floch, m.d.; Kris V. Kowdley, m.d.; 
C.S. Pitchumoni, m.d.; James 
Scolapio, m.d.; and Raul Rosen-
thal, m.d. (Saunders) This 
text covers the field of digestive 
diseases—including those related 
to gastroenterology, hepatol-
ogy, and nutrition. A templated 
format offers a quick summary of 
nearly 300 of the most commonly 
encountered clinical conditions, 
while the illustrations provided 
by Frank H. Netter, m.d., depict 
key anatomical structures and 
highlight important concepts.
The descriptions above are based 
on information from the publishers.
send notices of new books to
Cheryl Violante, Yale Medicine, 
300 George Street, Suite 773, 
New Haven, CT 06511, or via e-mail 
to cheryl.violante@yale.edu
on campus
Relying on the kindness  
of strangers
The central figure in Tracy Kidder’s 
new book escaped death by 
machete in his native Burundi, 
beat overwhelming odds to get 
an Ivy League education, and 
returned to his war-torn country 
to build a free clinic that treats 
what the author called “stupid 
illnesses,” which are often fatal 
in Africa but easily treated in the 
developed world.
In his book Strength in What 
Remains, Kidder maintains that 
the kindness of strangers shines 
even in a dark world, as he told an 
audience in Harkness Auditorium 
during a talk co-sponsored by 
Yale Cancer Center and wshu 
Public Radio in November. 
His book is the story of Deo, 
a survivor of an ethnic massacre 
who fled to New York City and 
slept in Central Park until a child-
less couple adopted him and 
paid his way through Columbia 
University. Deo was mentored 
by Paul Farmer, m.d., the sub-
ject of Kidder’s 2003 bestseller 
Mountains Beyond Mountains. 
Deo returned to Burundi and 
built the clinic with the help of 
strangers. The organization that 
Deo founded and that sponsors 
and operates this facility is called 
Village Health Works.
The center has treated 28,000 
patients since its opening in 2008. 
It has become “an instrument 
of peace,” Kidder said, because 
the various tribes put aside their 
“artificial” differences to realize 
“our common susceptibility to 
illness and injury.”
—John Dillon
Educating the public about  
science is an uphill battle
Sharon Begley, science editor of 
Newsweek, despairs of the chal-
lenge of educating the American 
public about science. Such issues 
as evolution, she said, have be-
come so politically charged that a 
rational discussion seems impos-
sible. “No amount of excellent 
journalism on evolution is likely to 
make a difference,” she said. “We 
can write it, but that doesn’t mean 
that people will believe it.”
In a talk sponsored by the 
Poynter Fellowship in November, 
Begley said that there is a large  
disconnect between factual  
knowledge and belief. “Human-
kind has practiced magical think-
ing and has relied on instinctual 
thinking and superstition much 
longer than it has relied on critical 
thinking,” she said. 
While people accept scien-
tific findings on noncontroversial 
topics—most, for example, be-
lieve correctly that the center  
of the planet is extremely hot—
the reverse is true for evolution. 
About half the population, she 
said, believes that humans and 
dinosaurs coexisted. And only 
21 percent know that dna is the 
molecule of heredity.
“Knowledge is not enough to 
support rational scientific think-
ing,” she said. “You have to want 
to think rationally.”
—John Curtis
S H A RO N B E G L E Y T R AC Y K I D D E R
In the early 19th century, aspiring physicians learned  




In March 1811, at the age of 22, Elijah 
Woodward Carpenter of Brattleboro, Vt.,  
signed his name to an indenture, a  
contract with Cyrus Washburn, a doctor 
in the nearby town of Vernon. Carpenter 
agreed to serve as Washburn’s appren-
tice for the next two years or more and  
pay him a fee of $133.33. In return Wash-
burn would provide room and board in 
his home, and would instruct Carpenter 
“personally and by the use of books, in 
the art & science of Anatomy, Surgery 
and Physic.”
At that time only a handful of Ameri- 
can medical schools existed, and 
Carpenter’s apprenticeship represented 
the most common form of medical 
training in the New World. The Medical 
Institution of Yale College had been 
chartered the previous year, but its first 
class, in which Carpenter would be one 
of 37 students, would not begin studies 
until November 1813. 
For the elite, premier medical train-
ing could be had in European univer-
sities. But for Carpenter—who was 
born in a log hut—university training 
in Europe was not an option. In fact, it 
took him three years to pay Washburn’s 
fee. For most Americans who wished 
to pursue medicine, apprenticeship to a 
local practitioner was the only option. 
The quality of the training, which 
usually lasted for two or three years, 
depended on the skills of the teacher. 
Often described as “reading with the 
doctors and riding with the doctors,” 
apprenticeship consisted of book 
study and a later phase in which the 
student attended his preceptor on his 
rounds—on horseback.
In exchange for his on-the-job learn-
ing, the apprentice did the “grunt work” of 
the medical practitioner. Carpenter agreed 
to “diligently during said term attend to 
the study, and art of practicing Physic, 
Surgery &c. and agreeably to the direc-
tions of the said Washburn from time to 
time, prepare & Compound medicines for 
his the said Washburn’s use.” Carpenter 
may have been lucky: Beyond compound-
ing medicines, apprentices often tended 
the horses and cleaned the stables. 
10 capsule
11
t o p  When Elijah Carpenter completed 
his studies, his instructor Cyrus Washington 
sent him off with a letter of recommenda-
tion that cited his good moral character and 
his success in his studies of medicine. 
mid d le  In the earliest days of the School 
of Medicine, students bought tickets to 
lectures. Elijah Carpenter, who began his 
studies with the first group of students to 
enter the school, attended a first course 
of lectures but could not afford a second.
bo t t om  In 1814 the state of Vermont 
issued a certificate attesting to Carpenter’s 
abilities in the practice of medicine.
o pp o site  page  This lithograph of 
Elijah Carpenter was made from a portrait 
photograph taken in early 1855, the year he 
died. After his apprenticeship and studies, 
Carpenter went on to a successful career as 
a physician and surgeon in Vermont.
Despite its shortcomings, apprentice-
ship offered a crude prototype of clinical 
training. It was the most practical system 
available, and physicians saw apprentice-
ship as one way to standardize medical 
training. In 1800, a committee of the 
Connecticut Medical Society, seeking 
to regularize physician education in the 
state, recommended that candidates 
wishing to practice medicine be at least 
21, have a good reputation, have a college 
education, and have two years of study 
with a respectable physician or surgeon.
When the apprenticeship concluded, 
the preceptor sent off his student with 
a written certificate, much like the one 
Washburn provided Carpenter in July 
of 1814 after Carpenter had attended 
one course of lectures at Yale’s fledgling 
medical institution. (Lack of funds pre-
vented Carpenter from taking a second 
course.) Washburn began his testimony 
by citing Carpenter’s “reputable family” 
and “good moral character.” Then  
he explained that Carpenter had “with 
much industry and success devoted 
three years to the theory & practice  
of Physic, Surgery &c. under my imme-
diate inspection.” 
Washburn’s certificate would be  
virtually worthless to anyone not famil-
iar with his skill, thus underscoring  
a major problem with apprenticeship: 
its authority resided with the precep-
tor. What was lacking was a standard 
and objective body of knowledge, and 
an institution to communicate such 
knowledge. As the medical school grew 
in stature, it would become the locus of 
science, and the medical profession in 
the middle and later parts of the 19th 
century would embrace both.
Carpenter went on to a successful 
career as a physician and surgeon in 
Vermont and was a surgeon’s mate  
in the Massachusetts militia. He died 
in Vermont in 1855.
This article has been adapted from a forth-
coming book by Kerry Falvey celebrating the 
bicentennial of the Yale School of Medicine. 




















Biotech after the bust
Five new Yale-affiliated biotech companies started up last year, but the industry sees problems ahead.
By Charles Gershman
Illustration by Rakefet Kenaan
After the U.S. and world economies faltered in the fall of 
2008, it became clear that future plans for Yale’s various activi-
ties were going to change. The signs around the country and 
the world were not auspicious. On September 15, 2008, the 
New York financial services firm Lehman Brothers filed for 
Chapter 11 bankruptcy protection. The next day, the insurance 
giant American International Group (aig) suffered a liquidity 
crisis after its credit rating was downgraded. aig’s stock had 
already dropped 60 percent before the market’s opening that 
day. The nation’s gdp then fell at a pace not seen since the 
1950s. The unemployment rate in the United States more than 
doubled, from 4.9 percent at the end of 2007 to 10.2 percent  
in October 2009. Outside Yale, layoffs and bankruptcies were 
taking place en masse. The ensuing $700 billion bailout pack-
age softened the blow but did not prevent belt tightening in 
boardrooms around the world and rising global unemployment.
Whatever immunity universities may have had to previ-
ous swings in financial markets, Yale couldn’t dodge the 2008 
bullet. On December 16 Yale President Richard C. Levin gave 
faculty and staff the bad news: all departments and offices at 
the university must find ways to cut costs. By June 2009, Yale’s 
endowment had lost 29 percent of its value, from $22.9 billion 
to $16.3 billion. The air—off campus and on—was filled with 
uncertainty. But in the Temple Street office of Jon Soderstrom, 
ph.d., it was business as usual.
The view from Temple Street
“In terms of new deals, we haven’t seen the downturn,” says 
Soderstrom, director of Yale’s Office of Cooperative Research 
(ocr), which helps Yale scientists found businesses based on 
promising discoveries. “Hardly a week goes by when we don’t 
get venture capitalists calling up to talk to us about what new 
things we have. … If you were to look at our performance last 
year, and you didn’t know anything about the economic down-
turn, you wouldn’t have guessed it.”
Last year, for example, saw five Yale startups. One 
of them, Kolltan Pharmaceuticals, launched by Joseph 
Schlessinger, ph.d., chair and William H. Prusoff Professor 
of Pharmacology, working in partnership with ocr, raised 
more than $35 million despite lean times. “Five is actually 
above our average,” Soderstrom says. “We’re [usually] in the 
three-to-four range. In terms of financing, we didn’t see a 
significant downtick in any of our numbers—licenses, royal-














Biotech after the bust
The number of new startups is not the only sign that 
New Haven biotech is on the rise. Office occupancy rates in 
New Haven are up, laboratory space is tight, and developers 
are racing to keep up, notes John Puziss, ph.d., ocr’s director of 
technology licensing. “Hopefully, with the economic crisis sort 
of easing and more money being available for investing in tech-
nologies, we’ll see more startups coming out of Yale,” he said.
But the increase in the number of new deals, Soderstrom 
notes, is only one side of the coin. Companies that are already 
up and running have seen some problems. “Although the 
number of new deals was steady, we were all too aware of the 
struggles of many existing ventures to attract new capital or 
stretch what they had to bridge the downturn.” And forces 
around the country appear to be limiting the growth in bio-
tech. According to the MoneyTree report from the accounting 
firm PricewaterhouseCoopers, only seven companies went 
public in the United States in January 2010 via initial public 
offerings (ipos)—a big drop from the monthly average of 
22.6 in 2007. In the United States, investment from venture 
capital dropped from $4.4 billion in 2008 to $3.5 billion in 
2009. The number of biotech deals also fell, from 501 in 
Kolltan Pharmaceuticals 
Kolltan, which has secured over  
$35 million in financing, is develop-
ing monoclonal antibodies against 
various cancers and hopes to move 
these antibodies into clinical trials.
founder
Joseph Schlessinger, ph.d., chair 




The company develops a series  
of implants and regenerative 
products for cartilage defect 
repair and joint fusion.
founder
John S. Reach Jr., m.d., assistant 
professor of orthopaedics and 
rehabilitation
CardioPhotonics
The company is developing and 
marketing technology that  
provides real-time, noninvasive 
blood volume monitoring.
founders
Kirk H. Shelley, m.d., ph.d., associate 
professor of anesthesiology
David G. Silverman, m.d., professor of 
anesthesiology
MiraDx
Yale Cancer Center researchers 
have pioneered a diagnostic test to 
identify individuals predisposed to 
lung, ovarian, and other cancers by 
examining genetic biomarkers.
founders
Frank Slack, ph.d., associate professor 
of molecular, cellular and developmen-
tal biology in the Graduate School of 
Arts and Sciences 
Joanne B. Weidhaas, m.d., ph.d., assis-
tant professor of therapeutic radiology
Oasys Water
The company is commercializing a 
technology that employs osmosis 
to produce fresh water from sea 
water or industrial waste water and 
uses 90 percent less energy than 
conventional desalination systems.
founders
Rob McGinnis, a doctoral student in 
environmental engineering in the Yale 
School of Engineering and Applied 
Science, and his advisor; 
Menachem Elimelech, ph.d., chair 
of the Department of Chemical 
Engineering and Roberto Goizueta 
Professor of Environmental and 
Chemical Engineering
2008 to 406 in 2009. (By contrast, 2007 saw 494 deals and 
$5.3 billion in venture capital invested.)
“The state of biotech nationally, even internationally, is 
in a difficult time right now because venture capital dollars 
have dried up. [The economic downturn] makes everybody, 
on paper, feel poorer. It makes [venture capitalists] more risk-
averse,” says Paul R. Pescatello, j.d., ph.d., president and ceo 
of Connecticut United for Research Excellence (cure), a non-
profit organization that supports bioscience in the state. 
But Pescatello adds that other factors have taken a toll 
on investment in biotech. The Sarbanes-Oxley Act of 2002, 
enacted to combat corporate corruption, accounting fraud, 
and mismanagement by extending government oversight of 
public (though not of privately held) companies, makes it more 
expensive to go public—especially for small companies. It’s 
not always feasible, says Pescatello, “to go public and incur the 
annual ongoing costs, the accounting costs, the auditing costs, 
the disclosure costs. … You see fewer companies going public 
to avoid that kind of regulatory and administrative burden.”
The debate over health care reform has also caused ten-
sion over patent life: the generic drug industry and lawmakers 
The five companies financed in 2009:
15
like Rep. Henry A. Waxman, a California Democrat who chairs 
the House’s Energy and Commerce Committee, are calling for 
a five-year patent limit on biologics (medicinal products that  
are made from living organisms) instead of the 12 years allowed 
for pharmaceuticals. “If you only have five years to recoup 
your investment,” Pescatello says, “no one’s going to invest 
in biotech.”
Another poorly defined area in health care reform has 
been reimbursement. How would biologics, pharmaceuticals, 
and other drugs and devices be reimbursed under health care 
reform? “That’s a big deal,” Pescatello says, because it’s impos-
sible to establish price points without knowing what the system 
will allow. “Investors hate uncertainty.”
William Wiesler, ph.d., director of new ventures at ocr, 
agrees that uncertainty about pending legislation leads to 
caution among investors. It happened in 1993: “When every-
body was worried that Hillary Clinton was going to nationalize 
medicine, all the pharma companies were down, and venture 
capitalists got a little sour on biotechs. But that didn’t last too 
long, and [investment] popped back up,” Wiesler says. “Some 
industries have a cyclicality that’s a little bit different than 
the rest of the market. And I am quite certain if the economy 
finally turns around and picks up, and unemployment drops ... 
and the nasdaq picks up that we’ll have another banner year 
with the venture capitalists.”
Nurturing a young industry
Few people know New Haven biotech better than venture capi-
talist David Scheer, whose New Haven-based firm, Scheer & 
Company, has helped to launch more than 10 biotech compa-
nies. His latest partnership with Yale is Axerion Therapeutics, 
a company formed in 2009 in partnership with ocr and Yale 
neurobiologist Stephen M. Strittmatter, m.d., ph.d. The com-
pany’s research efforts will focus on stimulation and regenera-
tion of axons in the brain and central nervous system, with the 
hope of reversing damage caused by traumas like spinal cord 
injury and stroke.
But Scheer & Company does more than launch biotech 
companies. “We’ve helped them in a variety of ways—recruiting, 
fundraising, taking them through the usual rounds of private 
financing, ipos, mergers and acquisitions transactions, busi-
ness development, partnerships,” Scheer says. He has served on 
Achillion Pharmaceuticals 
Innovative treatments for infec-
tious diseases (achillion.com)
founder
Yung-Chi Cheng, ph.d., Henry Bronson 
Professor of Pharmacology
Affomix Corporation
Antibody screening technology 
(affomix.com)
founder
Michael Snyder, ph.d., former Lewis 
B. Cullman Professor of Molecular, 
Cellular, and Developmental Biology 
and professor of molecular biophysics 
and chemistry
Alexion Pharmaceuticals
Treatments for rare diseases 
(alxn.com)
founders
Leonard Bell, m.d. ’84, former assis-
tant clinical professor of medicine  
and pathology
Joseph A. Madri, m.d., ph.d., hs ’76, 
professor of pathology
Applied Spine Technologies 
Spinal implant device  
(appliedspine.com)
founder
Manohar M. Panjabi, ph.d., profes-
sor emeritus of orthopaedics and 
rehabilitation
Axerion Therapeutics
Treatments for spinal cord injury  
and Alzheimer disease
founder
Stephen M. Strittmatter, m.d., ph.d., 
Vincent Coates Professor of Neurology 
and professor of neurobiology
BioRelix
Antibiotic discovery (biorelix.com) 
founder
Ronald Breaker, ph.d., Henry Ford II 
Professor of Molecular, Cellular, and 
Developmental Biology
Carigent Therapeutics
Drug delivery technology  
(carigent.com)
founders
W. Mark Saltzman, ph.d., chair and 
Goizueta Foundation Professor of 
Chemical and Biomedical Engineering
Tarek Fahmy, ph.d., assistant professor 
of biomedical engineering
cgi Pharmaceuticals 




Mark Velleca, m.d., ph.d., hs ’97, fw ’99, 
assistant clinical professor of labora-
tory medicine
Ira Mellman, ph.d., former Sterling 
Professor of Cell Biology and 
Immunology














the boards and as chair of all the New Haven-based companies 
he’s helped to launch. “It used to be easier to raise money,” says 
Scheer. “The capital markets are tighter.” In the current eco-
nomic climate, he says, venture capitalists need to support their 
existing portfolios. As a result less money is available for new 
investments in the life sciences. “Only the strongest companies 
are in a position these days to raise capital,” Scheer says.
A reputation in science
Just as Scheer nurtures his companies to success, Yale’s ocr 
has learned over the years to shepherd biotech firms from a 
notion in the lab to a full-fledged company with investors. ocr 
was created in 1982 after Congress enacted the Bayh-Dole Act 
of 1980, which allows universities to retain title to inventions 
resulting from federally supported research. The office got  
a boost in 1995 when the university tripled its budget and staff; 
hired a new director; and charged the office with founding 
and building local companies based on technology licensed 
from Yale. In the last 10 years, ocr has helped Yale scientists 
to found more than 40 companies that have in turn attracted 
more than $450 million in financing. The university earns 
between $10 and $20 million per year in royalties from the 
commercialization of licensed patents. (ocr has tracked pat-
ent applications since 1987. Since then, there have been 5,897 
applications filed and 1,483 patents issued in 54 countries.)  
“We are actively pursuing a portfolio of 1,306 applications 
worldwide,” says Diane K. Harmon, ocr’s director of intellec-
tual property administration.
To Soderstrom, Yale’s reputation and strength in the 
sciences is paramount. “Without quality science and technol-
ogy,” he says, “you don’t have a whole lot to trade on. Yale is a 
300-year-old institution, it’s considered to be one of the premier 
research institutions in the world, [and it] has a faculty that 
bespeaks that reputation.” Soderstrom cites the number of Yale 
faculty belonging to the National Academy of Sciences—59  
as of this writing—as a testament to the medical school’s depth 
and excellence. “Particularly from the perspective of the 
medical school, the quality of the technology, the quality of 
the science that’s performed at the medical school, continues 
to attract attention from investors and companies,” he says. 
“And I think we’ve gained a pretty good reputation for identi-
fying good ideas that people find worth investing in.”
Biotech after the bust
CoolSpine llc
Cooling catheter for use in  
cardiothoracic surgery
founder
John A. Elefteriades, m.d. ’76, 
hs ’81, fw ’83, William W.L. Glenn 
Professor of Surgery
Helix Therapeutics
Genetic repair therapies  
(helixtherapeutics.com)
founder
Peter M. Glazer, m.d., ph.d., Robert E. 




ing and diagnostics (historx.com)
founders
David L. Rimm, m.d., ph.d., professor 
of pathology
Robert L. Camp, m.d. ’97, ph.d., associ-
ate research scientist in pathology
JS Genetics
Genetic tests for Turner’s syndrome 
and dyslexia (jsgenetics.com) 
founders
Jeffrey R. Gruen, m.d., associate profes-
sor of pediatrics (neonatology), inves-
tigative medicine, and genetics
Allen E. Bale, m.d., professor of genetics
Scott A. Rivkees, m.d., professor of 
pediatrics (pediatric developmental 
biology and biophysics)
L2 Diagnostics
Infectious disease diagnostics 
founders
Erol Fikrig, m.d., Waldemar Von 
Zedtwitz Professor of Medicine
Joseph E. Craft, m.d., professor 
of medicine (rheumatology) and 
immunobiology
Richard A. Flavell, ph.d., chair and 
Sterling Professor of Immunobiology
Marinus Pharmaceuticals 
Therapeutics for psychiatric  
disorders (marinuspharma.com)
founder
Vincent A. Pieribone, ph.d., associate 
professor of physiology
mgs Research Inc.
Medical gel dosimetry systems 
(mgsresearch.com)
founders
Marek J. Maryanski, ph.d.
John C. Gore, ph.d., former professor 
of psychology
Robert J. Schulz, ph.d., professor emer-




Frank Slack, ph.d., associate professor 
of molecular, cellular, and develop-
mental biology
Joanne B. Weidhaas, m.d., ph.d., assis-
tant professor of therapeutic radiology
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Although the New Haven region—home to about 50 
biotech companies—enjoys a collaborative spirit, Connecticut 
faces particular challenges. “We’re part of a growing com-
munity that sees a very strong need to help each other and 
build out the economy of the area by investing in biotech,” says 
Susan Froshauer, ph.d., fw ’88, founding ceo and currently 
chief scientific officer of Rib-X Pharmaceuticals. The company 
aims to bring to market small-molecule antibiotics based on 
the work of 2009 Nobel laureate Thomas A. Steitz, ph.d., 
Sterling Professor of Molecular Biophysics and Biochemistry 
and professor of chemistry; Peter B. Moore, ph.d., Sterling 
Professor of Chemistry and professor of molecular biophysics 
and biochemistry; and William L. Jorgensen, ph.d., Sterling 
Professor of Chemistry. “In environments such as San Diego 
or Boston, there’s a larger critical mass,” Froshauer says, “and 
so there’s more of a momentum that has been sustainable, 
even through hard times.”
Whether Connecticut has a pool of talent large enough 
to meet the local need is a sticking point. In Connecticut 
and at Yale, says Scheer, “there is absolutely no dearth of 
great technology. But one of the critical issues that we have  
found over the years is recruiting ceo talent. Some of the more 
business-oriented pharmaceutical executives tend to be in  
other places. They have their families, kids, et cetera, in places  
like Princeton or Boston or New Jersey or the Bay Area, and 
they just don’t want to move.”
But New Haven’s biotech economy is also a young one. 
“When you’re talking about size, we’re never going to be that 
[large],” says Soderstrom, referring to more established biotech 
centers around the country. “What we can do is be really good  
at what we have.” Soderstrom says the local market has begun 
to sustain itself, so ocr no longer needs to be chiefly respon-
sible for all new ventures. “There was a time when we were  
putting together the PowerPoint presentations, making the calls  
to the investors, doing the pitch with investors, helping to 
recruit the talent, actually negotiating leases on space. We don’t 
have to do a lot of that stuff anymore, because there’s already 
talent stepping in and doing those kinds of things.” YM
Charles Gershman is an assistant editor at Yale School of Medicine’s office of 
Institutional Planning and Communications.
New Haven Pharmaceuticals 
Therapeutics for depression and GI 
disorders (newhavenpharma.com)
founders
John H. Krystal, m.d. ’84, hs ’88, 
Robert L. McNeil, Jr., Professor of 
Clinical Pharmacology
John P. Geibel, m.d., ph.d., associate 
professor of surgery (gastroenterology)
Wajahat Z. Mehal, ph.d., assistant pro-
fessor of medicine (digestive diseases)
Gerard Sanacora, m.d., ph.d., assistant 
professor of psychiatry
Vladimir Coric, m.d., associate clinical 
professor of psychiatry
Optherion
Therapeutics and diagnostics for 
age-related macular degeneration 
(optherion.com)
founder
Josephine J. Hoh, ph.d., associate 
professor of epidemiology and 
ophthalmology
PGxHealth, a division of  
Clinical Data
Biomarker discovery and drug  
development (pgxhealth.com)
founder
Gualberto Ruaño, m.d. ’97, ph.d. ’97
PhytoCeutica
Traditional Chinese botanical 
remedies developed into fda-
approved drugs for cancer  
(phytoceutica.com)
founder
Yung-Chi “Tommy” Cheng, ph.d., Henry 
Bronson Professor of Pharmacology
Rib-X Pharmaceuticals
Antibiotic drug discovery and 
development (rib-x.com)
founders
Thomas A. Steitz, ph.d., Sterling 
Professor of Molecular Biophysics and 
Biochemistry (and co-recipient of the 
2009 Nobel Prize in Chemistry)
Peter B. Moore, ph.d., Sterling Professor 
of Chemistry and professor of molecu-
lar biophysics and biochemistry
William L. Jorgensen, ph.d., Sterling 
Professor of Chemistry
SurExam
Ovarian cancer diagnostics  
for Chinese market
founder
Gil G. Mor, m.d., m.sc., ph.d., associate 
professor of obstetrics, gynecology, 
and reproductive services
Vascular Insights llc
ClariVein catheter for treating var-
icose veins (vascularinsights.com) 
founders
John P. Marano Jr., ph.d. ’69
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As research becomes more  
interdisciplinary, architects  




After 15 years in his warren of offices and lab space on the sixth 
floor of the Laboratory of Epidemiology and Public Health, 
where he studies how ticks spread Lyme disease and ehrlichio-
sis, Durland Fish, ph.d., has grown fond of its dark nooks 
and labyrinthine passageways. But by 2008 plans were in the  
works for renovations that would transform the floor into a 
more open, communal atmosphere—and pull Fish, professor 
of epidemiology, into the 21st-century world of science architec-
ture. “Renovations have to be done,” he conceded. “I personally 
am not looking forward to it.” New interior windows will make 
the floor more transparent, and Fish doesn’t want to think he’s 
working in a fishbowl. “I don’t want anybody peeking in and 
seeing what I’m doing,” he said. “I want to get my work done  















And that’s why a “plug-and-play” approach guides the  
design of lab modules, said architect J. Ian Adamson, a 
principal with Payette Associates of Boston—the firm that 
co-designed The Anlyan Center and designed the additions 
to the Sterling Hall of Medicine’s B wing. “As people come 
and go and research ebbs and flows, you’re not doing a lot 
of renovation. It looks like an Erector Set. These [new labs] 
are easy enough that the principal investigators could change 
things on a weekend and not have to put in a requisition order.” 
Desks, tables, and benches in the Amistad Street Building, for 
instance, are on casters and can be reconfigured easily. The 
generic design “stops some 800-pound gorilla from saying,  
‘I want to do the lab,’ and when he retires, they’re stuck with 
this idiosyncratic lab,” Adamson said.
Academic fiefdoms are “a battle we deal with all the 
time” in building renovations, said Michael E. Schrier, project 
manager for facilities construction and renovation at the school, 
who has overseen renovations to many of the older structures. 
Once the building is renovated, the facilities “are turned over to 
the assigned department. If within five years Department A  
left, Department B could come in with little or no work at all.”
As science has changed, so has another element of lab 
design: support space. Historically, architects had set aside 
30 square feet of support space for every 100 square feet of lab 
space; however, that ratio increased even as The Anlyan Center 
was under construction. Part of Schrier’s job is to make room 
by squeezing utilities that were once out in the open—plumb-
ing, electrical, and computer lines—into walls and ceilings. 
With scientists spending more time at computers and in con-
trolled environments, newer designs require that each square 
foot of lab space be matched by a square foot of support space. 
“We’re finding that far more time is spent in these specialized 
support rooms than on the benches, hence the shift in the 
ratio,” said Adamson. Temperature and humidity control have 
become more important in many fields, and “air displacement 
can have a huge effect.” 
The school takes pains to give researchers what they 
need, said Chapman, while Larimer added, “You have to 
remind them that it’s a generic space.” 
Flora M. Vaccarino, m.d., a professor in the Child Study 
Center, said she was happy to see renovations under way at 
Sterling’s I-Wing, where her lab investigates the responses of 
neural stem cells to genetic and environmental factors; but she 
wondered about the allocation of space. As priorities change 
Science by Design
But science and architecture are moving in a new direc-
tion—away from the era in which a laboratory was built to 
order for a single principal investigator. While both new build-
ings and renovations to older ones aim to provide more support 
space for scientists, they also offer flexibility. Designed more 
like mittens than gloves, modern lab buildings include a little 
wiggle room. More ample common areas encourage mingling 
among scientists. And if a researcher departs for new academic 
pastures, their space can easily accommodate a new scientist. 
Yale has been on an ambitious quest to increase lab 
space and improve its existing labs since the early 2000s. The 
Anlyan Center, which opened in 2003 at a cost of $172 mil-
lion, was a major step. Its 450,000 square feet increased the  
school’s research space by 25 percent. The Amistad Street 
Building, which opened in 2007 with an $88-million price 
tag, added another 120,000 square feet. The school also spent 
$14 million in 2002 on a 23,700-square-foot extension of 
the Sterling Hall of Medicine’s B wing. By 2011, the school 
will have spent an additional $467 million in renovations to 
various lab buildings, not including Amistad, The Anlyan 
Center, and the B wing extension, or the West Campus in 
neighboring Orange and West Haven. Because of the eco-
nomic slowdown, plans for renovations to the West Campus 
have slowed down and construction of a new building on 
the main medical campus is on hold. The medical school is 
awaiting word on applications to nih for construction fund-
ing for other projects.
Despite these expansions, the way in which space is dis-
tributed and used by researchers remains an issue. The new 
philosophy in interior design promotes interaction among dis-
ciplines and provides more comfortable digs for collaboration  
to take place. At the same time, the new spaces segregate 
offices from laboratories, partly to discourage researchers from 
eating in their labs—food can contaminate experiments—but 
also to allow reconfigurations as circumstances change.
In the past, said M. Virginia Chapman, m.arch. ’85, 
director of construction and renovation for facilities at  
the School of Medicine, “every lab was tailored to the specific 
needs of the researcher. … It was so specific that you had to  
do a comprehensive renovation when a new user came in.” 
And, said Reyhan T. Larimer, project manager for facili-
ties construction and renovation at the School of Medicine, 
noting the often transient nature of academic life, “The major 
trend in lab design is generic, flexible design.”
pr e v i o us page  Although 
many scientists have grown used 
to working in a warren of offices 
and laboratories, a new philosophy 
in laboratory design promotes 
interaction among disciplines and 
encourages collaboration. 
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“Science itself is becoming more interdisciplinary,” Adamson 
said. “Boundaries between departments are breaking down 
across the board.”
At The Anlyan Center, corridors and even the stairway  
landings act as meeting spaces, whether planned or impromptu.  
X-ray readers, for example, are in the hallway outside the 
anatomy teaching lab to promote group discussions.
The lengthy corridors that bisect Anlyan separate offices 
and research spaces; in Amistad, the offices are bookends 
between the labs. “In the old days, you could have your office in 
the labs,” Chapman said. “That’s something that’s hard to do 
now. The idea is to create open laboratories to allow for flexibil-
ity. If you insert offices midway through these labs, you create 
labs that cannot grow or contract with research needs.”
The medical school has heard some grumbling about 
the division. “People don’t like having their offices remote from 
their labs,” Chapman said, “so we try to make the offices as 
close to the labs as possible.” Since food and beverages aren’t 
allowed in the labs, shelving units or “coffee cubbies” are 
placed outside each lab so researchers can store a cup of coffee 
or other food items while they are in the lab. (At the newer 
Amistad Building, the “coffee cubbies” are tall enough to 
accommodate a Starbucks venti-sized cup.)
Fostering that water cooler collegiality, however, requires 
more than redesigning the physical plant. Jeffrey R. Bender, 
m.d., the Robert I. Levy Professor of Medicine (cardiology) 
and professor of immunobiology, notes that such labs as his, 
at the end of a corridor at The Anlyan Center, tend to be self-
contained. And the labs between the ends might be occupied 
entirely by a senior faculty member with abundant grants. 
Such labs, Bender said, could have up to 36 work stations for 
one PI. “An assistant professor is going to get four to eight work 
stations,” he said.
And that’s where the interactions are likely to occur—in 
a large lab space occupied by up to half a dozen assistant pro-
fessors and their lab groups. “Their graduate students and post-
docs are going to be sharing the same space,” Bender said.
Girish Neelakanta, ph.d., a postdoctoral fellow in infec-
tious disease, has worked in such a lab in The Anlyan Center 
for four years and finds it encourages collegiality in several 
ways. One is its location near other lab buildings. And within 
the building itself, he said, it’s easy to talk to other scientists. 
His first-floor lab, where he works on Lyme disease, is shared 
by four principal investigators.
with funding, space needs in laboratories also change. “What 
happens when labs undergo major changes in research direc-
tions?” Vaccarino asked. 
A square peg in a round hole
The Amistad Street Building, which opened in 2007, offers  
an example of both the new philosophy at work and the 
perennial space problems facing the medical school. Amistad 
became a starter home for the Yale Stem Cell Center as  
well as the Human Translational Immunology program and 
the Vascular Biology and Transplantation program. In less  
than three years, however, the Stem Cell Center, which had 
been scattered around the campus, has expanded to six 
independent research laboratories and eight faculty members 
housed in roughly 30,000 square feet. “We have four new 
recruits,” said Diane S. Krause, m.d., ph.d., associate direc-
tor of the center. “Now that they’ve moved in, we will soon  
be bursting at the seams.” 
Krause, a professor of laboratory medicine, cell biology,  
and pathology, appreciates the communal aspect of the 
Amistad building, which has lounges in the middle of the 
floors where researchers can gather. “It is nice to have these 
opening areas where people can interact,” she said.
Creating such gathering spots is a key element in 
designing new research space. “Where will the next Nobel 
Prize project develop?” said Robert Venturi, whose firm 
Venturi, Scott Brown and Associates co-designed The Anlyan 
Center. “In the lab? The meeting space? The café?” 
To create that common shared space, The Anlyan Center 
is split into two wings—three stories for teaching and six sto-
ries for research—that are connected by walkways and share 
a lobby. The purpose of the lobby “was to simulate a street 
going through, a communal space between two buildings,” 
said Larimer. In the research wing, 450-foot-long corridors end 
in lounges that are part kitchenette, part cafeteria, and part 
mini-lecture hall. Blackboards (which won the battle against 
whiteboards in this instance) dominate one wall opposite fixed 
benches, with tables and chairs scattered about. The benches 
were added so that researchers could catch forty winks. “You 
get folks who are in these buildings for long hours,” Adamson 
said. “If you build these lounges, they can lie down and 
stretch out for two hours.”
Promoting multidisciplinary chats at the water cooler is 
















display. Most labs, however, retain their original openness. 
Because the building was designed for transparency, it was left 
up to the departments and researchers to either keep it that 
way or have a modicum of seclusion. 
Venturi said that science buildings should have work 
spaces near windows at the building’s exterior “for enjoying the 
amenity of natural light and the view,” while the mechanical 
space belongs in the center and on the top. The Anlyan Center, 
whose architecture is based on that of an old New England 
mill, follows that thinking even in the third-floor anatomy lab.  
“Because it has a lot of windows, it was controversial,” Adamson  
said. “We thought it was important to have natural light in 
there. If you’re stuck in a windowless room six hours a day, 
it’s depressing.”
Though Adamson said that most scientists are “more 
than happy to work in a shared space,” not everyone is fond  
of breaking the labs open; some researchers still prefer their 
warrens and cubicles. 
“That attitude is really waning,” said Bender. “You can 
have a chunk of space that you feel is your own. It is more 
generic and it’s more flexible. If you need two extra benches, 
you don’t need to invade someone else’s room.” YM
John Dillon is a freelance writer in New Haven.
“Here we are all friendly. We share a lot of equipment,” 
he said. “You can talk to postdocs working on different projects.”
Sarojini Adusumilli, ph.d., also a postdoc in infectious 
disease, echoes Neelakanta’s comments. “We share ideas with 
people when we meet in the break room,” she said. “The break 
room is a place where we talk about science. Maybe someone 
saw a paper and they thought it was interesting. We also dis-
cuss the problems of science and the kind of work we do.”
But the building’s layout also encourages interdisciplin-
ary conversations. “Doctors and postdoctoral researchers can all 
interact,” she said. “People working in basic science as well as 
clinical science can discuss things.”
A few miles away, the interdisciplinary approach is driv-
ing plans for the West Campus. Built in several stages over a 
period of years, the former Bayer facility has almost half a  
million square feet of pristine lab space for both biology and 
chemistry researchers. Unlike spaces on the medical school 
campus, West Campus will not be home to generic labs but  
to specialized core facilities and new institutes dedicated to 
specific fields of research. George Zdru, director of capital 
programs at the medical school’s facilities office, notes that so 
far three core research facilities—the Yale Center for Genome 
Analysis, the Center for High Throughput Cell Biology, and 
the Small Molecule Discovery Center—have opened up on the 
West Campus with few modifications to existing space. Five 
institutes are in the preliminary stages of planning—microbial 
biology, chemical biology, cancer biology, systems biology, and 
cell biology. “At this point it is hard to tell how much restruc-
turing will be required,” Zdru said. “The West Campus in its 
totality is being thought of as a multidisciplinary environment 
by the nature of the definition of the institutes. The three pri-
mary research buildings are interconnected. Inherently, there is 
a multidisciplinary nature to the planning of West Campus.”
A room with a view
More glass and better lighting are dominant features in both 
the new buildings and the refurbished ones on the medical 
school campus. A driving force behind that is Yale’s sustain-
ability initiative that aims to reduce energy use. But the school 
also desires more openness in its labs, which had been “like 
rabbit warrens,” Chapman said. 
At The Anlyan Center some interior windows have been 
treated with translucent film or otherwise covered to offer pri-
vacy for occupants who don’t want everything they do on public 
New ideas in lab design encourage 
interdisciplinary cross talk and  
collaboration through common  




New assistant dean  
for education 
janet p. hafler, m.ed., ed.d., 
has been appointed assistant dean 
for educational scholarship in the 
office of education. Hafler, who 
began her career as a registered 
nurse, earned a master’s degree in 
education from Teachers College  
of Columbia University and a doc-
torate in education from Harvard 
University. Hafler comes to Yale 
with extensive experience in the 
medical schools of Harvard and 
Tufts, where she worked in faculty 
development. At both schools  
she addressed teaching, learn- 
ing assessment, and curriculum 
development. At Yale Hafler will 
work with faculty and residents  
to improve teaching and learning. 
She will develop and implement 
educational programs and individ-
ual educational consultations, and 
work on defining and evaluating 
educational contributions. 
One new program she plans 
to start is a fellowship for faculty 
in medical education. The project 
will begin in July with one or two 
faculty members from each of five 
departments. Each participant will 
design a resident-as-teacher pro-
gram for training residents to teach 
medical students as well as fellow 
residents. Hafler is also developing 
metrics for evaluating teaching. 
Richard Belitsky, m.d., deputy dean 
for education, noted that Hafler’s 
appointment coincides with the 
medical school’s decision to review 
its curriculum with an eye toward 
strategic revisions. “There was a 
clear consensus,” he said, “to bring 
to Yale someone with expertise in 
medical education who is trained 
as an educator.”
Change in primary 
care clerkship
frederick d. haeseler, m.d., 
fw ’76, has stepped down as head 
of the fourth-year primary care 
clerkship that he has directed since 
1993. peter j. ellis, m.d., m.p.h., 
assistant professor of medicine, 
took over effective January 1.
Haeseler founded the clerk-
ship in 1993 with a grant from the 
Robert Wood Johnson Foundation 
for curriculum reform. The goals  
of the reform included increasing  
medical student exposure to pri-
mary care and developing outpa-
tient educational sites for clinical 
clerkships. The present month-long 
clerkship includes a combination 
of faculty-led discussion groups on 
key primary care topics and super-
vised patient care in community-
based practices and clinics. 
The transition comes as the 
medical school begins a strategic 
planning process covering the 
entire four-year curriculum. Ellis  
is interested in exploring several 
contemporary themes in primary 
care, including the patient-centered 
medical home, outpatient clinical 
reasoning, and cost containment. 
One of the principal goals of the 
clerkship, said Ellis, is to “enable 
students to perform an accurate 
problem-focused patient assess-
ment in an ambulatory setting.”
Haeseler will continue to direct 
the standardized patient program 
that he also founded in 1993. He 
writes scripts for the program and 
trains actors to portray patients 
with a variety of medical disorders. 
Medical students then interview 
and examine the standardized 
patients to learn and practice clini-
cal skills. Haeseler will also continue 
to mentor students as an attending 
physician at haven, the student-
run free clinic in New Haven’s Fair 
Haven neighborhood.
Steven B. Leder, ph.d., professor of 
surgery (otolaryngology), has been 
installed as the incoming president 
of the Dysphagia Research Society 
for 2010-2011. The society is an in-
ternational organization devoted 
to all aspects of swallowing and 
its disorders. Leder is involved in 
clinical care. He also does research 
in dysphagia diagnostics and re-
habilitation for patients with head 
and neck cancer, as well as other 
acute and long-term diseases, 
voice restoration following total 
laryngectomy, and voice reha-
bilitation following tracheotomy 
and ventilator dependency. Leder 
received his doctorate from the 
University of Connecticut and is a 
fellow of the American Speech-
Language-Hearing Association.
Ruslan Medzhitov, ph.d., the 
David W. Wallace Professor of 
Immunobiology and a Howard  
Hughes Medical Institute Invest- 
igator, has received the 2010 
Lewis S. Rosenstiel Award for 
Distinguished Work in Basic 
Medical Science. The award was 
conferred for Medzhitov’s “elu-
cidation of the mechanisms of 
innate immunity.” Medzhitov’s 
studies helped shed light on  
“the critical role of Toll-like recep- 
tors (tlrs) in sensing microbial 
infections, mechanisms of tlr sig-
naling and activation of the inflam- 
matory and immune response.”  
Rosensteil Awards are given to 
scientists for recent discoveries  
of particular originality and im- 
portance to basic medical research. 
A $30,000 prize and a medal  
accompany each award. Sharing 
the award for his work in innate 
immunity is Jules Hoffman, ph.d., 
Research Director and Member 
of the Board of Administrators of 
the National Center of Scientific 
Research, University Louis Pas-
teur, Strasbourg, France.
Murat Günel, m.d., hs ’98, has 
been named the Nixdorff-German 
Professor of Neurosurgery. Günel, 
also professor of neurobiology 
and of genetics, is co-director of 
the Yale Neurogenetics Program 
and studies genetic risk factors 
for neurovascular disease. He re- 
ceived his medical degree from 
Istanbul School of Medicine in  
Turkey and completed his residency  
in neurosurgery at Yale-New 
Haven Hospital in 1998. That same 
year, he joined the School of Medi- 
cine faculty as an assistant pro-
fessor of neurosurgery. Günel 
has been chief of the Section of 
Neurovascular Surgery since 2001 
and a full professor of neuro- 
surgery since 2008.
David A. Hafler, m.d., chair 
of neurology at the School of 
Medicine, has been named the 
inaugural Gilbert H. Glaser, m.d., 
Professor of Neurology. Hafler, 
a leader in the effort to better 
understand the molecular basis of 
multiple sclerosis, joined the fac-
ulty in September. An authority 
on the mechanisms of autoimmu-
nity and inflammatory diseases 
of the central nervous system, 
he was previously director of 
molecular immunology in the 
neurology department of Harvard 
Medical School, where he was the 
Jack, Sadie, and David Breakstone 
Professor of Neurology (Neuro-
science) and a neurologist at 
Brigham and Women’s Hospital. 
Hafler also received the John J. 
Dystel Prize for Multiple Sclerosis 
Research from the American 
Academy of Neurology in January. 
The prize is given in recognition  
of his outstanding achievements 
in multiple sclerosis research. The  
award comes with a $15,000 prize.


















Andres Martin Kevin PelphreyCarolyn Mazure
Past Yale winners of the 
Rosenstiel Award include: in 
2008, Arthur L. Horwich, m.d., 
Eugene Higgins Professor of 
Genetics and Pediatrics and 
Howard Hughes Medical Insti-
tute Investigator, for his work 
in the field of protein-mediated 
protein folding; in 2002, Joan A. 
Steitz, ph.d., Sterling Professor 
of Molecular Biophysics and Bio-
chemistry and Howard Hughes 
Medical Institute Investigator, 
for her work in establishing a 
subfield of molecular biology 
concerning small nuclear ribonu-
cleoproteins; in 2001, Thomas A. 
Steitz, ph.d., Sterling Profes-
sor of Molecular Biophysics and 
Biochemistry and Chemistry and 
Howard Hughes Medical Institute 
Investigator, who later won the 
2009 Nobel Prize in Chemistry;  
in 1989, Sidney Altman, ph.d., 
Sterling Professor of Molecular, 
Cellular, and Developmental 
Biology, for discovering the 
catalytic properties of rna. 
Altman won the Nobel Prize in 
Chemistry the same year.
Andres S. Martin, m.d., 
m.p.h. ’02, was appointed the 
Riva Ariella Ritvo Professor of 
Pediatric Psychosocial Services in 
December. Martin, an associate 
professor of child psychiatry  
and psychiatry in the Yale Child 
Study Center, is also the medical 
director of the Children’s Psychi-
atric Inpatient Service at Yale-
New Haven Children’s Hospital.
Carolyn M. Mazure, ph.d., profes-
sor of psychiatry and psychology 
and associate dean for faculty 
affairs, was inducted into the 
Connecticut Women’s Hall of 
Fame in October for her work 
that explores gender-specific 
 differences in the causes, treat-
ment, and prevention of cancers, 
osteoporosis, depression, and 
other disorders more prevalent 
in women. Mazure created the 
Women’s Health Research at Yale 
(whry) program in 1998 based 
on the premise that understand-
ing gender differences is vitally 
important to the health of both 
women and men. whry—which 
Mazure began with a grant from 
the Patrick and Catherine Weldon 
Donaghue Medical Research 
Foundation of West Hartford—
has grown to become a national 
model for conducting research 
on women’s health and dissemi-
nating findings with real-world 
benefits to the community. 
Kevin Pelphrey, ph.d., has been 
named the Harris Family Associ-
ate Professor of Child Psychiatry in  
the Child Study Center. Pelphrey 
studies brain mechanisms under- 
lying the development of differ-
ent aspects of social cognition.  
His interests include the develop-
ment of social perception, the 
perception and regulation of 
emotion, and the development 
of theory of mind—a crucial 
cognitive capacity defined as the 
ability to make inferences about 
the mental states of others. 
Pelphrey completed his doctorate 
in psychology at the University 
of North Carolina, Chapel Hill, in 
2001. He then held a postdoctoral 
fellowship in cognitive neuro-
science at Duke University. He 
remains a core faculty member of 
Duke University’s Brain Imaging 
and Analysis Center. Pelphrey is 
a frequent collaborator with col-
leagues in Yale’s Department of 
Psychology; he is also a mem-
ber of the Interdepartmental 
Neuroscience Program and the 
Cognitive Science Program.
Nancy H. Ruddle, ph.d. ’68, 
professor emerita and senior 
research associate in the Division 
of Epidemiology of Microbial 
Diseases in the School of Public 
Health, received the 2009 Life-
time Achievement Award from 
the International Cytokine Society 
at its annual meeting in Lisbon, 
Portugal, in October. The award is 
given annually to a scientist who 
has contributed to research on  
cytokines, proteins released by  
cells within the immune system 
that are critical to regulating 
the body’s immune response. 
Ruddle’s research, which began 
during her years as a graduate 
student in microbiology at Yale, 
focuses on lymphotoxin and 
other cytokines involved in auto-
immune diseases and lymphoid 
organ development.
Gerald I. Shulman, m.d., ph.d., 
the George R. Cowgill Professor of 
Physiological Chemistry, profes-
sor of medicine and of cellular 
and molecular physiology and a 
Howard Hughes Medical Institute 
Investigator, was named a fellow 
of the American Association for 
the Advancement of Science 
(aaas) in December. He is one of 
531 aaas members elevated to 
this rank last year for their efforts 
toward advancing science ap-
plications that are deemed scien-
tifically or socially distinguished. 
Shulman was honored for his 
contributions to the understand-
ing of type 2 diabetes, notably the 
mechanisms of insulin resistance 
and the metabolic syndrome, a 
cluster of risk factors for diabetes 
and heart disease. 
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William V. Tamborlane, m.d., 
fw ’77, professor and section 
chief of pediatric endocrinology 
and deputy director of the Yale 
Center for Clinical Investigation, 
has been honored with the Diabe-
tes Technology Leadership award 
by the Diabetes Technology 
Society for his lifetime accom-
plishments in diabetes research 
and technology. Tamborlane’s 
achievements have included pio-
neering work in the development 
of insulin pump therapy, continu-
ous glucose monitoring, sensor-
augmented pumps, closed-loop 
systems, and development of 
an artificial pancreas. He also 
demonstrated the role of insulin 
resistance in pediatric metabolic 
disorders, including obesity and 
type 2 diabetes.
Robert I. White, m.d., professor of 
diagnostic radiology, received the 
2010 Career Achievement Award 
from the International Sympo-
sium on Endovascular Therapy 
at its annual meeting in Florida 
in January. White, the director of 
the Yale Vascular Malformation 
Center, is credited with developing 
four new procedures in vascular 
interventional radiology, includ-
ing embolization of pulmonary 
arteriovenous malformation 
and varicocele, and percutane-
ous valvuloplasty for pulmonary 
valve stenosis and coarctation 
restenosis. He has authored two 
textbooks and more than 300 pa-
pers. His honors include a Gold 
Medal and Leaders in Innovation 
award from the Society of Inter-
ventional Radiology, of which he 
is a past president.
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students
New PA grads face  
a bright future
Physician associates can help solve 
some of the biggest problems in 
health care.
“It’s a great time to be a physician 
associate,” said Robert S. Galvin, m.d., 
in a Commencement address given 
in December to 35 new graduates of 
Yale’s Physician Associate Program. 
Galvin, the executive director of 
health services and chief medical officer 
of General Electric, told the graduating 
class that their profession is “close to 
t o p  Robert Galvin, chief medical officer of Gen-
eral Electric, told physician associate graduates that 
they can help solve some of the biggest problems 
in health care, such as the shortage of physicians.
abov e  Dean Robert Alpern awarded a 
diploma to Dominique Caruso.
r i ght  Students Carolyn Canonica, Emily Bur-
gun, Nicholas Bonomo, and Sarah Bailey waited 









recession-proof” because their skills are 
in such demand. Physician associates, 
he said, can help solve several of the big-
gest problems in health care, such as the 
shortage of physicians, the expanding 
need for health care, and rising costs. 
All of these issues will be intensified, he 
added, once Congress passes a health 
care reform bill that could bring 30 mil-
lion currently uninsured people into the 
health care system. 
Galvin advised the graduates to 
become lifelong learners, because the 
ongoing explosion in medical knowl-
edge constantly renders old information 
obsolete. He also urged them to treat 
their patients with kindness.
Three students were given special 
honors: Dominique Caruso received 
the Dean’s Academic Award for excel-
lence in the classroom; Lauren Swisher 
received the Dean’s Clinical Award for 
distinction in the clinical portion of the 
program; and Megan Dieterich won the 
Dean’s Humanitarian Award for volun-
teer work at the haven free clinic.
The students also gave three awards 
of their own: to Rex L. Mahnensmith, 
m.d., professor of medicine, for excel-
lence as a teacher; to the Clover Fork 
Clinic in Evarts, Ky., for providing 
exemplary clinical teaching; and to 
Rita Rienzo, pa-c, m.m.sc., assistant 
professor in the Physicians Associates 
Program, who accepted the Jack Cole 
Society Award for her support of stu-
dents and the profession. 
Robert J. Alpern, m.d., dean of the 
Yale School of Medicine and Ensign 
Professor of Medicine, congratulated the 
graduates and handed out the diplomas. 
And lastly, as a sonorous recessional was 
played on the Woolsey Hall pipe organ, 
35 new physician associates marched 
















Hunger and Homelessness 
Auction raises funds for local 
organizations
Tarot card readings, a vintage Epiphone 
guitar, a chance to challenge the dean’s 
softball team, and an afternoon of handy 
work by second-year medical students 
were on the block on Nov. 19 at the 17th 
Annual Hunger and Homelessness 
Auction sponsored by the Yale Health 
Professional Schools.
This year the auction netted about 
$25,000 for local nonprofits whose pro-
grams combat hunger and homelessness. 
In the past, grants have been awarded 
to such agencies as the Community 
Health Care Van, Loaves and Fishes, the 
Community Soup Kitchen, and Domestic 
Violence Services.
Traditional items were offered 
during the live auction in Marigold’s, 
including a bow tie belonging to 
William B. Stewart, ph.d., associate 
professor of surgery and chief of the 
Section of Anatomy and Experimental 
Surgery. (The tie, which “smells 
faintly of formaldehyde,” fetched 
$900.) Stewart also offered his usual 
Beef and Beer Dinner for eight, which 
fetched an additional $900. Nancy R. 
Angoff, m.p.h. ’81, m.d. ’90, hs ’93, 
associate dean for student affairs, and 
Margaret J. Bia, m.d., professor of 
medicine, reprised their “Girls’ Night 
Out”—“Share good food, great com-
pany, juicy gossip, and worldly wisdom 
with Drs. Peggy Bia, Jean Vining, Joni 
Hansson, and Nancy Angoff. (Dinner 
for girls only).” The dinner was worth 
$800 to a group of medical students.
And continuing into his fourth 
year, Wade Brubacher, a professional 
auctioneer from Kansas and father 
of medical student Jake Brubacher, 
offered his services and led the bidding.
The live auction came after a 
silent auction that began on Monday, 
Nov. 16. The silent auction included 
offerings of clothing, dinners, food, 
and lessons in language, arts, dance, 
and sports. Assorted services offered 
included trips to Costco, gofer services 
for one business day, computer help, 
and a personal tour of the Big Apple 
from a native New Yorker.
—John Curtis
t o p  Medical student Stacey Kallem offered a 
bid on a “girls’ night out” with faculty including 
Nancy Angoff and Margaret Bia. 
abov e le f t  Nursing students Katherine 
Magoon, Meaghan Hamilton, and Emily Miller 
perused the list of items before the start of  
the live auction.
abov e r i ght  Auctioneer Wade Brubacher 
cajoled first-year medical student Nathan  





















Edward Halperin, dean of the School of Medicine 
at the University of Louisville, believes that 
knowledge of the cultural, historical, and philo-
sophical underpinnings of medicine is essential 
to medical education.
Keeping body and  
soul together
For one doctor, history and the  
other humanities are a vital part  
of medicine.
If you type the name “Halperin EC” 
into the medical journal search engine 
PubMed, the results—nine pages 
worth—seem to be the works of dif-
ferent authors. There are articles about 
brain tumors and radiation treatments. 
But then there’s one about the theft 
of the bodies of African Americans 
for anatomy classes in the late 18th 
and early 19th centuries. There is one 
entitled “The pornographic anatomy 
textbook?” And there is “Should aca-
demic medical centers conduct clinical 
trials of the efficacy of intercessory 
prayer?” All were written by Edward 
C. Halperin, m.a., m.d. ’79, a pediat-
ric radiation oncologist, dean of the 
School of Medicine at the University of 
Louisville, Ky., and a passionate devotee 
of the liberal arts.
“Physicians like to be convinced 
that they’re rarified and scientific,” 
Halperin said, “but medicine is a social 
activity that takes place in the context 
of its times.” Knowledge of the cultural, 
historical, and philosophical underpin-
nings of medicine, he believes, is central 
to medical education. When he became 
dean at Louisville in 2006, Halperin  
instituted three compulsory humani-
ties classes for medical students—
Intersection of Religion and Medicine, 
History of Medicine, and Literature 
in Medicine—and helped start a joint 
m.d./m.a. in medical humanities there. 
He earned a master’s in liberal studies 
himself while at his previous post as vice 
dean of Duke University’s School of 
Medicine, attending classes like The 
Human-Animal Boundary, Travel Writ-
ing in the Ancient World, and South 
African History.
For his master’s thesis on drug 
screening of medical residents, he asked 
doctors-in-training at Duke whether 
they thought drug tests violated their 
civil rights. They didn’t, it turned out. 
“Interns and residents are so accultur-
ated to jumping through hoops, that if 
you say ‘Urinate in the cup,’... They say,  
‘Which way is the bathroom?’ ” He is 
troubled by evidence that criminal back- 
ground checks on medical students are 
racist—minor crimes like marijuana 
possession can lead to very different con-
sequences for minorities as opposed to 
affluent whites. And he is leery of medi-
cal students doing “audition electives” at 
faraway hospitals in the hopes of match-
ing at competitive residencies, since the 
inherent expense discriminates against 
less affluent students.
A native of Somerville, N.J., Halperin 
developed a passion for ethics and hu-
man rights in childhood. He idolized 
lawyers, including a relative who sat on 
New Jersey’s Supreme Court, as well as 
then-Justice Department lawyer Nicholas 
Katzenbach. Katzenbach’s 1963 “school-
house door” confrontation with Gov. 
George Wallace, who opposed desegrega-
tion at the University of Alabama, deeply 
impressed Halperin. After seeing photos 
of the event, he decided to become a civil 
rights lawyer. Eventually, though, he 
realized that most lawyers don’t wind up 
on supreme courts or engaged in historic 
civil rights struggles. “I might end up 
having to do parking tickets, divorces, 
house closings,” he remembers thinking. 
“That might not make a really big dif-
ference in society. 
It was then that Halperin turned 
to medicine. He chose radiation oncol-
ogy in part because he felt it was one 
of the most consequential, high-stakes 
things a doctor could do. He trained at 
Stanford and at Massachusetts General 















The granddaughter of a  
legend finds her own way  
as a physician
Sally Winternitz, m.d., hs ’86, grew 
up in northern New Jersey consumed 
by things that are typically only  
passing fancies for little girls—riding 
horses, playing in the woods, and  
collecting shells. At 16, her passions 
took a turn when she decided that  
she wanted to attend medical school. 
“I didn’t think of it as being part of  
a family tradition,” she said. Whatever 
the spark, Winternitz’s decision  
continues a rich heritage of medicine 
initiated by her ancestors.
Winternitz’s grandfather, Milton 
Charles Winternitz, m.d., a second-
generation physician, reigned as dean  
of the School of Medicine from 1920  
to 1935, during which time he boosted 
the school to elite status and established  
the Yale system of medical educa-
tion. Her grandmother, Helen Watson 
Winternitz, m.d., earned her medical 
degree at Johns Hopkins before marry-
ing Milton, although she declined to 
practice medicine in favor of raising  
her children.
Despite never really knowing her 
grandparents—Winternitz was 5 when 
her grandfather passed away in 1959, 
and her grandmother had died 29 years 
earlier in the prime of her life—she 
feels that her grandparents exerted an 
unconscious influence on her and her 
relatives, one that has guided many of 
them toward medicine. “Why did eight 
of my cousins become physicians?” 
Winternitz wondered. “We have a good 
proportion of a medical school class. 
That was my grandfather’s life’s work—
running a medical school.”
For much of Winternitz’s life her 
father, Tom, talked little of her grandfa-
ther, as the two had broken ties many 
years before. “Great men sometimes  
are great men, but not great parents,”  
she said. Winternitz believes that her 
grandfather’s hot temperament led to the 
schism between the two. Perhaps strain-
ing their relationship was the decision 
The patients Halperin cares for are 
indeed those who force doctors to think 
about whether the world makes sense. 
“Doctors have a lot of rationalizations 
that get them through the day,” he said. 
A long-time smoker with untreated 
hypertension who has a stroke, or a 
woman with cervical cancer who had 
dozens of sexual partners and never 
got a Pap smear may prompt a doctor 
to privately rationalize that the patient’s 
irresponsibility is to blame. “But there’s 
nothing to blame when a 7-year-old has 
leukemia,” he said. “Children with can-
cer bring up the problem of evil.”
Medicine and the humanities are 
part of the culture of Halperin’s family. 
His wife, Sharon, and his eldest daugh-
ter, Rebecca, are physical therapists; the 
two of them recently volunteered their 
expertise in Nicaragua. His middle 
daughter, Jennifer, works in fashion 
as a dress buyer for Victoria’s Secret, 
while his youngest, Alison, is a senior 
at Barnard College and studies limb 
injuries and artificial limbs during the 
Civil War.
That interest in medical history is 
part of the cultural legacy Halperin 
tries to impart to his students. One of 
his most remarkable articles concerns 
a 1971 anatomy textbook that included 
chauvinist remarks and photographs  
of women in an alluring pin-up style; 
the textbook met with outrage and  
was withdrawn soon after publication. 
“The story of discrimination against 
blacks and Jews and Catholics and 
women is part of the story of medicine, 
and is worth telling,” he said. “If we fail 
to tell these tales and remember our 
history, we’ll be the worse for it.”
—Jenny Blair, M.D. ’04
made by Tom, the eldest son, not to 
pursue a career in medicine. Instead 
he followed the path of his maternal 
grandfather, Thomas Watson, who with 
Alexander Graham Bell invented and 
developed the telephone. Tom Winternitz 
worked as an electrical engineer with 
Bell Laboratories for 40 years.
Sally Winternitz started medical 
school at Rutgers in New Jersey and 
after two years transferred to Tufts 
in Boston, graduating in 1980. She 
pursued internal medicine as her older 
brother Charlie had done, which took 
her to a residency at Case Western 
Reserve University in Cleveland. But 
Winternitz soon realized that psychia-
try is her true calling. She completed 
two years of internal medicine at Case 
Western, focusing heavily on neurology 
due to her plans to pursue psychiatry. 
Then the break she was waiting for 
appeared: she was offered a spot in the 
general psychiatry training program 
at Yale—a department founded by her 
grandfather more than 50 years earlier.
Since completing the Yale program 
in 1986, Winternitz has worked in 
inpatient and outpatient psychiatry set-
tings. She feels privileged to be allowed 
to share in the very intimate struggles 
raging within her patients and to be 
trusted enough to lead them toward 
solutions. “Spiritually, there isn’t a much 
better place to be than being in the ser-
vice of others, and that’s really important 
to me,” she said.
Winternitz lives in Sequim, Wash., 
on the Olympic Peninsula, sheltered by 
the Olympic Mountains on one side and 
a view of the Strait of Juan de Fuca sepa-
rating the United States and Canada on 
the other. She runs a small psychiatry 




Do you have a colleague who is making  
a difference in medicine or has followed 
an unusual path since leaving Yale? We’d 
like to hear about alumni of the School of 
Medicine; Physician Associate Program; 
and the medical school’s doctoral, fellow-
ship, and residency programs. Drop us a 
line at ymm@yale.edu or write to Faces, 
Yale Medicine, 300 George Street, Suite 
773, New Haven, CT 06511.
two days per week, and also serves as 
a psychiatric consultant at a local com-
munity health center. The balance of 
Winternitz’s time is devoted to her hus-
band, Matthew Barton, m.d., an anesthe-
siologist, and her two teenage children, 
son Jay and daughter Babette. 
Over the past few years, Winternitz 
has done a lot of questioning to de-
termine the role of her grandparents in 
her life. She clearly recognizes the cul-
ture of medicine that they unknowingly 
fostered within the family. However, 
her revelations go deeper: “What’s 
interesting to me in a synchronistic way 
is that my life in some ways parallels 
my grandmother’s, except that I get to 
live mine and she died.” When Helen, 
a much beloved wife and mother, died 
from probable renal failure at the age 
of 45, she left behind five children 
between the ages of five and 14, and 
a dark void within the family. “The 
irony and sad part was that here was 
this world-famous physician who had a 
wife he couldn’t heal,” says Winternitz. 
“Lucky me, I’m married to a physician, 
I get to be a physician myself, and I get 
to raise my kids.”
—Kara A. Nyberg
Sally Winternitz carries on a family tradition  
of entering medicine. A psychiatrist in the 
Pacific Northwest, she is the granddaughter 










•	 Alumni	lectures:	 		Robert	Klitzman,	m.d. ’85 — When Doctors Become Patients
Jerrold M. Post, m.d. ’60 — When Illness Strikes the Leader
•	 The	Legacy	of	Harvey	Cushing	at	Yale:	Past	and	Future	Perspectives	
•	 Tours	of	Medical	Library,	medical	campus,	West	Campus,	 
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1960s
Helen L. Smits, m.d. ’67, was 
inducted into the Connecticut 
Women’s Hall of Fame in October. 
Smits, a retired physician-manager  
whose most recent work has 
been in Mozambique and other 
countries in  sub-Saharan Africa, 
was honored for her work as an 
international health care leader 
and teacher. She currently serves 
as a senior consultant to the Doris 
Duke Foundation’s African Health 
Initiative. She is the former direc-
tor of the John Dempsey Hospital 
at the University of Connecticut 
Health Center in Farmington, and 
is a former member of the board 
of directors of the Hartford Stage.
1970s
Colleen Livingston, m.d., hs ’73, 
fw ’75, was recognized as a 
Distinguished Life Fellow by the 
American Psychiatric Association 
at the annual meeting in San 
Francisco last year. Livingston 
has a private practice in Canton, 
NY. She has a special interest in 
mood and anxiety disorders.
1980s
Howard S. Jaffe, m.d. ’82, is presi-
dent of the Gilead Foundation 
and a member of Gilead’s senior 
management team. Gilead is a 
nonprofit that seeks to improve 
the health and well-being of 
underserved communities around 
the world through expanding 
access to hiv and hepatitis B 
education, outreach, prevention, 
and health services. He has been 
a member of the management 
team since 1991, serving in such 
roles as chief medical officer and 
senior vice president for drug 
development. Prior to joining 
Gilead, Jaffe was director of clini-
cal research and cytokine project 
team leader at Genentech.
From 2002 to 2004, he served 
as research director at the Gordon 
and Betty Moore Foundation. 
Jaffe is a former faculty member 
at the University of California, 
San Francisco, and has served  
as an attending physician in in-
ternal medicine at San Francisco 
General Hospital. 
Diane Louie, m.d. ’87, m.p.h., 
wrote to say that after several 
years as an attending patholo-
gist	at	Memorial	Sloan-Kettering	 
Cancer Center, in New York, she 
reinvented herself. She earned 
a degree in Health Policy and 
Management at Columbia and 
moved from academic medicine 
to the pharmaceutical industry. 
After positions at Merck & Co. 
and Roche, she now works at 
Sanofi-Aventis, where she is a 
regulatory liaison to the fda, 
developing oncology drugs and 
companion diagnostic tests. She 
lives in Madison, N.J., with her 
husband, Paul Rothenberg, m.d., 
ph.d., who works in the phar-
maceutical industry as a clinical 
pharmacologist.
2000s
Jennifer Davids, m.d. ’05, and 
Matthew Davids, m.d. ’05, 
announced the birth of their first 
child, Emily Isabella, on August 20, 
2009. “Emily couldn’t wait to see 
everyone, so she decided to come 
a month early. Mom, Dad, and 
baby are all doing well.” Jennifer 
is a general surgery resident at 
Brigham and Women’s Hospital. 
Matthew is a hematology/oncol-
ogy fellow in Harvard’s combined 
Dana-Farber Cancer Institute, 
Brigham and Women’s Hospital, 
and Massachusetts General 
Hospital program. They live in 
Boston.
George Lui, m.d. ’02, was 
recently appointed director of 
adult congenital heart disease at 
Montefiore Medical Center, and 
assistant professor of medicine 
and pediatrics at the Albert 
Einstein College of Medicine in 
the Bronx, N.Y. He also received 
the Outstanding Research Award 
in Pediatric Cardiology at the 
American Heart Association’s 
2009 Scientific Sessions.
Jordan M. Prutkin, m.d. ’02, 
was married on December 5 to 
Heather S. Camp, r.n., m.p.h., a 
nurse with the Seattle branch of 
a company that provides nursing 
and medical staff to hospitals 
and other organizations. Prutkin 
is an assistant professor in the 
medicine-cardiology department 
at the University of Washington 
School of Medicine in Seattle. 
Michael Singer, m.d. ’02, ph.d. ’02, 
has completed his work with 
HealthHonors, a behavioral eco- 
nomics company that he co-
founded in 2006. He is now at the 
Novartis Institutes for Biomedical 
Research, where he’s working on 
early-stage drugs for ophthalmol-
ogy. He lives in Newton, Mass. 
with his wife, Baha, an optom-
etrist, and their two children, Leili 
and Samia.
Barbara A. Wexelman, m.d. ’08. 
m.b.a. ’08, was married on 
October 24 to David S. Spar, m.d., 
hs ’08, in Westhampton Beach, 
N.Y. Wexelman is a second-year 
resident in general surgery at 
St. Luke’s-Roosevelt Hospital in 
Manhattan. Spar is a second-year 
fellow in pediatric cardiology at 
New York-Presbyterian/Columbia 
University Medical Center. 
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Karel B. Absolon, m.d. ’52, ph.d., 
died of respiratory failure on 
October 2 at his home in Rockville, 
Md. He was 83. Born in Brno in 
what is now the Czech Republic,  
Absolon left in 1948 during 
the Communist takeover of his 
homeland. A heart surgeon, he 
was chief of surgery at Wash-
ington Hospital Center and also 
worked at the National Institutes 
of Health. He retired from the 
National Heart, Lung, and Blood 
Institute in the mid-1980s. Abso-
lon was a collector of history and 
medical books and wrote a three-
volume biography of Theodor 
Billroth, the father of modern 
gastrointestinal surgery.
Sophia Chamberlin Alway, 
m.d. ’41, died on February 10, 
2009, in Redmond, Wash. She 
was 92. Alway completed her 
residency in pediatrics at the 
University of Minnesota, where 
she met her husband, also a  
pediatrician. The couple moved  
to Portola Valley, Calif., in 1955 
when her husband, Robert H. 
Alway, m.d., became dean of 
Stanford Medical School.
Donald S. Baim, m.d. ’75, a 
cardiologist and medical device 
executive, died on November 6  
in Natick, Mass., following surgery 
for adrenal cancer. He was 60. 
Baim, a former professor of medi-
cine at Harvard, most recently 
was chief medical o≤cer at 
Boston Scientific Corp., a manu-
facturer of medical devices. Baim 
established the interventional 
cardiology program at Beth Israel 
Deaconess Medical Center, which 
specialized in teaching surgeons 
to use such new devices as stents. 
He also edited the standard medi-
cal textbook for using the devices, 
now in its seventh edition.
Albert W. Diddle, m.d. ’36, died 
on	December	23	in	West	Knoxville,	
Tenn. He was 100. Diddle com-
pleted his residency in obstetrics/
gynecology at the University of 
Iowa. He served as a physician in 
the U.S. Navy in the Pacific and 
China during World War II. After 
the war he trained in oncology at 
Parkland Hospital in Dallas, Texas. 
He	moved	to	Knoxville	in	1948,	
where he was the first board-
certified ob/gyn. He was on the 
planning committee for the 
University of Tennessee Medical 
Center there and was one of the 
original researchers of birth con-
trol pills. He published more than 
130 papers during his career.
Peter A. Duncan, m.d. ’41, died on 
September 25 in Greenwich, Conn. 
He was 93. Duncan served as a 
captain in the U.S. Army during 
World War II and practiced pedi-
atrics in Rye, N.Y. In the late 1970s 
he founded the Birth Defects Cen-
ter of Westchester County Medi-
cal Center and New York Medical 
College in Valhalla, N.Y. Duncan, a 
pioneering researcher in pediatric 
dysmorphology, wrote more than 
150 research articles and abstracts.
John L. Howland, med ’61, died on 
October 18 in Brunswick, Maine. 
He was 73. Howland joined the 
faculty of Bowdoin College in 
1963 as an assistant professor of 
biology and by 1971 had elevated 
biochemistry into a separate 
department. He served as chair 
of the department several times 
and retired in 2002. He was best 
known for his research into the 
causes of muscular dystrophy 
and the cellular biochemistry of 
genetic disorders.
Alan M. Levine, m.d. ’74, hs ’80, 
founder and director of the Alvin 
& Lois Lapidus Cancer Institute 
for Sinai Hospital and Northwest 
Hospital Center in Baltimore, 
died on October 25 in Pikesville, 
Md., of a heart attack. He was 61. 
Levine was renowned in his field 
as an expert on scoliosis. He was 
editor-in-chief of the Journal of 
American Academy of Ortho-
paedic Surgeons for eight years; 
his published works included  
Skeletal Trauma and Nonoperative 
Musculoskeletal Care. From 1976 
to 1978, he was a commissioned 
officer with the U.S. Public Health 
Service. Levine was director of 
the orthopaedic rehabilitation 
unit at Montebello State Hospital 
from 1980 to 1986. From 1983 to 
1998, he was chief of orthopaedic 
oncology service and director 
of the spinal injury clinic at the 
University of Maryland Medi-
cal Center. In addition to his 
professional success, Levine was 
active in charitable works. One 
of his hobbies was making teddy 
bears to explain the procedure of 
scoliosis surgery to children facing 
it and reduce their fears.
John R. Lyddy, m.d., hs ’57, died 
on October 3 at Bridgeport Hospi-
tal. He was 90. A graduate of the 
College of the Holy Cross and nyu 
College of Medicine, Lyddy com-
pleted his residency in ob/gyn at 
Yale. He served as a naval officer 
during World War II and the 
Korean	conflict.	He	practiced	gen-
eral medicine in Bridgeport in his 
early years and then established 
a private practice in Stratford. He 
also served at Bridgeport Hospital 
for many years, both as chair of 
ob/gyn and chief of staff. Lyddy 
was an accomplished carpenter 
and avid golfer. He loved sports, 
particularly the New York Mets.
Donald M. Mandelbaum, m.d., 
hs ’72, died of brain cancer on 
October 15 in Hollywood, Fla.  
He was 69. Mandelbaum received 
his medical degree from New 
York University in 1965. After in-
ternships in New York and service 
in the U.S. Army, Mandelbaum 
completed a three-year diagnos-
tic radiology residency at Yale.  
In 1972 he moved to Hollywood to 
join a radiology practice.
Hoyt B. Miles, m.d. ’43, died on 
October 20 in Reno, Nev. He was 
91. Although he played piano and 
flute in high school and won two 
national orchestral contests, Miles 
decided on medicine when he 
observed that the local musicians 
were poor and that the family 
doctor had two cars. After his 
graduation from medical school 
he served as a doctor with the 3rd 
Marine Division on Guam. He also 
served in China with the Marines. 
After World War II he resumed 
surgical training and practiced 
urology in Los Angeles. In 1958 
he opened a practice in Reno. 
Lawrence E. Shulman, ph.d. ’45, 
m.d. ’49, died on October 10 at 
his home in Washington, d.c., 
from complications of bladder 
cancer. He was 90. Shulman 
helped to found the Johns 
Hopkins University medical 
school’s rheumatology depart-
ment and was founding director 
of the National Institute of 
Arthritis, Musculoskeletal, and 
Skin Diseases. He joined the 
staff of the National Institutes 
of Health in 1976; in 1994 he 
was named director emeritus of 
the arthritis institute. Shulman 
received numerous national 
and international awards and 
fellowships for his service to the 
field of medicine, including the 
infrequently given Gold Medal 
of the American College of 
Rheumatology. 
Harris B. Shumacker Jr., m.d., 
hs ’38, died on November 12 in 
Gladwyne, Pa. He was 101. A 
graduate of the medical school 
of Johns Hopkins University, 
Shumacker was a pioneer in heart 
surgery and author of more than 
600 professional articles and 
papers, eight books and mono-
graphs and chapters in about 
40 textbooks. He was an expert 
in such areas as frostbite and the 
early development of the artificial 
heart. He served as an officer 
in the U.S. Army; as consultant 
to the surgeon general, he was 
instrumental in putting the first 
monkey into space in 1949. 
Alvin Somberg, m.d. ’47, died 
on October 13 in Chicago. After  
his graduation from the School  
of Medicine, Somberg, a general 
and family practitioner, served  
in the U.S. Army in France and 
spent most of his medical career 
















Back to the (not medical) boards
On two nights in January, in a lecture hall in the Jane Ellen Hope Building, a dozen 
students in medicine, public health, law, and the Physician Associate Program for-
got their studies and took on new roles. For the third year in a row, the Yale Med 
Players presented a night of one-act plays, this year adding the first act of Oscar 
Wilde’s The Importance of Being Earnest.
The troupe started four years ago when then-first-year medical students 
Abigail Baird and Scott Hunter, theater buffs in high school, rekindled their inter-
est in theater and staged a reading of The Doctor Stories by Richard A. Selzer, m.d., 
hs ’61. A year later, with support from Thomas P. Duffy, m.d., professor of medi-
cine (hematology), and director of the Humanities in Medicine program, the group 
decided to perform Selzer’s plays. 
Their production this year, “Lost in Transplantation,” deliberately 
eschewed medical themes. “We felt that we wanted to try something different, 
something really funny, so we picked comedies,” said Baird.
—John Curtis
Medical student Ramy Goueli played Algernon 
and Alexandra Sowa, a medical student from 
nyu at Yale for a fellowship, played Lady Brack-
nell in Oscar Wilde’s The Importance of Being 
Earnest. The YaleMed Players also performed the 
comedies The Statue of Bolivar and The Philadel-
phia, and Class Action, a monologue.
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